Podcast
Questions and Answers
What are the three essential components of regenerative medicine?
What are the three essential components of regenerative medicine?
Genes, cells, and matrix.
Explain the role of the extracellular matrix (ECM) in tissue regeneration.
Explain the role of the extracellular matrix (ECM) in tissue regeneration.
The ECM provides structural support, regulates cell behavior, and influences the processes of tissue regeneration.
What significant advancement was highlighted by Sir Peter Medawar in the 20th century?
What significant advancement was highlighted by Sir Peter Medawar in the 20th century?
The importance of immune rejection in transplantation.
What are stem cell niches and why are they important?
What are stem cell niches and why are they important?
Signup and view all the answers
Identify the three embryonic layers formed during gastrulation.
Identify the three embryonic layers formed during gastrulation.
Signup and view all the answers
What are the four phases of the organ-genetic period of embryonic development?
What are the four phases of the organ-genetic period of embryonic development?
Signup and view all the answers
What types of proteins are categorized as fibrous proteins in the ECM?
What types of proteins are categorized as fibrous proteins in the ECM?
Signup and view all the answers
How does the interaction between cells and ECM influence tissue regeneration?
How does the interaction between cells and ECM influence tissue regeneration?
Signup and view all the answers
What is the primary origin of the epidermis in skin development?
What is the primary origin of the epidermis in skin development?
Signup and view all the answers
How does intramembranous ossification differ from endochondral ossification?
How does intramembranous ossification differ from endochondral ossification?
Signup and view all the answers
What type of mesoderm is responsible for developing skeletal muscle?
What type of mesoderm is responsible for developing skeletal muscle?
Signup and view all the answers
In cardiac muscle development, from which embryonic tissue does it primarily arise?
In cardiac muscle development, from which embryonic tissue does it primarily arise?
Signup and view all the answers
What role do neural crest cells play in the development of the peripheral nervous system?
What role do neural crest cells play in the development of the peripheral nervous system?
Signup and view all the answers
What process allows cells to lose epithelial characteristics and become more mobile?
What process allows cells to lose epithelial characteristics and become more mobile?
Signup and view all the answers
How does Mesenchymal-Epithelial Transition (MET) contribute to tissue repair?
How does Mesenchymal-Epithelial Transition (MET) contribute to tissue repair?
Signup and view all the answers
What are Bone Morphogenetic Proteins (BMPs) essential for in development?
What are Bone Morphogenetic Proteins (BMPs) essential for in development?
Signup and view all the answers
What are cadherins and what role do they play in tissue formation?
What are cadherins and what role do they play in tissue formation?
Signup and view all the answers
How do integrins function in relation to the extracellular matrix (ECM)?
How do integrins function in relation to the extracellular matrix (ECM)?
Signup and view all the answers
Why is the skin crucial in protecting the body from external threats?
Why is the skin crucial in protecting the body from external threats?
Signup and view all the answers
What are the complications associated with severe burns?
What are the complications associated with severe burns?
Signup and view all the answers
How does skin's ability to self-repair change after severe injuries?
How does skin's ability to self-repair change after severe injuries?
Signup and view all the answers
What is the significance of using REIMS/i-knife in burn treatment?
What is the significance of using REIMS/i-knife in burn treatment?
Signup and view all the answers
What is a primary disadvantage of split-thickness skin grafts?
What is a primary disadvantage of split-thickness skin grafts?
Signup and view all the answers
How do autologous cell treatments reduce the risk of rejection in skin grafts?
How do autologous cell treatments reduce the risk of rejection in skin grafts?
Signup and view all the answers
What role does bromelain play in burn wound debridement?
What role does bromelain play in burn wound debridement?
Signup and view all the answers
What limitations does a xenograft have in burn treatment?
What limitations does a xenograft have in burn treatment?
Signup and view all the answers
Why is timing crucial when using Cultured Epithelial Autografts (CEAs) for skin coverage?
Why is timing crucial when using Cultured Epithelial Autografts (CEAs) for skin coverage?
Signup and view all the answers
What is a potential risk associated with receiving an allograft for burn treatment?
What is a potential risk associated with receiving an allograft for burn treatment?
Signup and view all the answers
Describe the composition of skin grafts from the dermal-epidermal junction in ReCell Spray-on Skin treatment.
Describe the composition of skin grafts from the dermal-epidermal junction in ReCell Spray-on Skin treatment.
Signup and view all the answers
What cell types play a crucial role in the healing of skin wounds?
What cell types play a crucial role in the healing of skin wounds?
Signup and view all the answers
How do Cultured Epithelial Autograft (CEA) sheets facilitate wound healing?
How do Cultured Epithelial Autograft (CEA) sheets facilitate wound healing?
Signup and view all the answers
What risk is associated with delayed surgical intervention after skin injury?
What risk is associated with delayed surgical intervention after skin injury?
Signup and view all the answers
Why is the extracellular matrix (ECM) significant beyond mere structural support in skin regeneration?
Why is the extracellular matrix (ECM) significant beyond mere structural support in skin regeneration?
Signup and view all the answers
What are two types of matrices mentioned for burn treatment and their key characteristics?
What are two types of matrices mentioned for burn treatment and their key characteristics?
Signup and view all the answers
How does Apligraf differ from other skin substitutes?
How does Apligraf differ from other skin substitutes?
Signup and view all the answers
What role do stem cells play in future innovations for skin regeneration?
What role do stem cells play in future innovations for skin regeneration?
Signup and view all the answers
What are the benefits of 3D bioprinting in tissue engineering?
What are the benefits of 3D bioprinting in tissue engineering?
Signup and view all the answers
What is a major challenge related to the use of dermal scaffolds in skin regeneration?
What is a major challenge related to the use of dermal scaffolds in skin regeneration?
Signup and view all the answers
How do adjunct therapies enhance the outcomes of skin treatments?
How do adjunct therapies enhance the outcomes of skin treatments?
Signup and view all the answers
What unique feature of cultured allogeneic grafts limits their use?
What unique feature of cultured allogeneic grafts limits their use?
Signup and view all the answers
What is the role of fibroblasts in skin regeneration?
What is the role of fibroblasts in skin regeneration?
Signup and view all the answers
Why is early treatment crucial for skin wounds?
Why is early treatment crucial for skin wounds?
Signup and view all the answers
What is the significance of utilizing autologous keratinocyte preparations in skin therapy?
What is the significance of utilizing autologous keratinocyte preparations in skin therapy?
Signup and view all the answers
What has been identified as an emerging area of focus for improving skin regenerative therapy?
What has been identified as an emerging area of focus for improving skin regenerative therapy?
Signup and view all the answers
What is the role of multipotent stem cells (MSCs) in tissue regeneration?
What is the role of multipotent stem cells (MSCs) in tissue regeneration?
Signup and view all the answers
How do MSCs contribute to the immune response during inflammation?
How do MSCs contribute to the immune response during inflammation?
Signup and view all the answers
What was the founding mission of FACT in the field of cellular therapies?
What was the founding mission of FACT in the field of cellular therapies?
Signup and view all the answers
What is the significance of accreditation in the BMT field as promoted by FACT?
What is the significance of accreditation in the BMT field as promoted by FACT?
Signup and view all the answers
In what ways do MSCs support the haematopoiesis niche in bone marrow?
In what ways do MSCs support the haematopoiesis niche in bone marrow?
Signup and view all the answers
What are the primary characteristics that distinguish ATMPs from other biological products?
What are the primary characteristics that distinguish ATMPs from other biological products?
Signup and view all the answers
Explain the regulatory role of the Office of the Gene Technology Regulator (OGTR) concerning GMOs in ATMPs.
Explain the regulatory role of the Office of the Gene Technology Regulator (OGTR) concerning GMOs in ATMPs.
Signup and view all the answers
Define biologicals according to the Australian Regulatory Guidelines for Biologicals.
Define biologicals according to the Australian Regulatory Guidelines for Biologicals.
Signup and view all the answers
What types of products are classified as biological medicines, and how do they differ from biologicals?
What types of products are classified as biological medicines, and how do they differ from biologicals?
Signup and view all the answers
Why is it significant that some ATMPs contain genetically modified organisms (GMOs)?
Why is it significant that some ATMPs contain genetically modified organisms (GMOs)?
Signup and view all the answers
How does substantial manipulation of cells or tissues play a role in classifying a product as an ATMP?
How does substantial manipulation of cells or tissues play a role in classifying a product as an ATMP?
Signup and view all the answers
What is the primary purpose of administering products that include recombinant nucleic acids?
What is the primary purpose of administering products that include recombinant nucleic acids?
Signup and view all the answers
Can you provide an example of a combination product within the ATMP category?
Can you provide an example of a combination product within the ATMP category?
Signup and view all the answers
What is the purpose of the Gene Technology Regulator in managing ATMPs containing GMOs?
What is the purpose of the Gene Technology Regulator in managing ATMPs containing GMOs?
Signup and view all the answers
Identify two key facilities or services provided by the Cell and Tissue Therapies WA (CTTWA).
Identify two key facilities or services provided by the Cell and Tissue Therapies WA (CTTWA).
Signup and view all the answers
What primary skill set is required for staff handling ATMPs in a cleanroom facility?
What primary skill set is required for staff handling ATMPs in a cleanroom facility?
Signup and view all the answers
What is the significance of Major Histocompatibility Complex (MHC) matching in hemopoietic stem cell transplantation?
What is the significance of Major Histocompatibility Complex (MHC) matching in hemopoietic stem cell transplantation?
Signup and view all the answers
Explain the role of CAR T-cell therapy in treating cancer.
Explain the role of CAR T-cell therapy in treating cancer.
Signup and view all the answers
What challenges are presented by the global shortage of corneal transplant materials?
What challenges are presented by the global shortage of corneal transplant materials?
Signup and view all the answers
What are mesenchymal stem cells (MSCs) and where can they be found?
What are mesenchymal stem cells (MSCs) and where can they be found?
Signup and view all the answers
How did the National Marrow Donor Program (NMDP) impact stem cell donations?
How did the National Marrow Donor Program (NMDP) impact stem cell donations?
Signup and view all the answers
What is the current standard of treatment for loss of corneal endothelial cells?
What is the current standard of treatment for loss of corneal endothelial cells?
Signup and view all the answers
Describe the importance of quality systems and Standard Operating Procedures (SOPs) in ATMP facilities.
Describe the importance of quality systems and Standard Operating Procedures (SOPs) in ATMP facilities.
Signup and view all the answers
What role do scaffolds play in tissue engineering?
What role do scaffolds play in tissue engineering?
Signup and view all the answers
Name two types of signals that influence cell behavior in tissue engineering.
Name two types of signals that influence cell behavior in tissue engineering.
Signup and view all the answers
What is a primary challenge faced in the development of tissue engineering solutions?
What is a primary challenge faced in the development of tissue engineering solutions?
Signup and view all the answers
How do biomaterials contribute to the function of scaffolds?
How do biomaterials contribute to the function of scaffolds?
Signup and view all the answers
What are the three sources of cells commonly used in tissue engineering?
What are the three sources of cells commonly used in tissue engineering?
Signup and view all the answers
Describe the significance of the extracellular matrix (ECM) in tissue engineering.
Describe the significance of the extracellular matrix (ECM) in tissue engineering.
Signup and view all the answers
What are the key characteristics that scaffolds must have for successful tissue regeneration?
What are the key characteristics that scaffolds must have for successful tissue regeneration?
Signup and view all the answers
How does mechanotransduction influence tissue engineering?
How does mechanotransduction influence tissue engineering?
Signup and view all the answers
What are bioinks and why are they significant in bioprinting?
What are bioinks and why are they significant in bioprinting?
Signup and view all the answers
Name two challenges associated with extrusion-based bioprinting.
Name two challenges associated with extrusion-based bioprinting.
Signup and view all the answers
What role does collagen play in tissue biomechanics?
What role does collagen play in tissue biomechanics?
Signup and view all the answers
Describe the importance of tailoring scaffold size and shape in tissue engineering.
Describe the importance of tailoring scaffold size and shape in tissue engineering.
Signup and view all the answers
What distinguishes biodegradable synthetic polymers from natural polymers in scaffold fabrication?
What distinguishes biodegradable synthetic polymers from natural polymers in scaffold fabrication?
Signup and view all the answers
Explain what Melt Electrowriting (MEW) is and one of its benefits.
Explain what Melt Electrowriting (MEW) is and one of its benefits.
Signup and view all the answers
What is the significance of cell contractility in tissue engineering?
What is the significance of cell contractility in tissue engineering?
Signup and view all the answers
In tissue engineering, what are the implications of using 3D scaffolds?
In tissue engineering, what are the implications of using 3D scaffolds?
Signup and view all the answers
What are two primary types of heart valves in current clinical use, and one characteristic of each?
What are two primary types of heart valves in current clinical use, and one characteristic of each?
Signup and view all the answers
How do scaffolds influence cellular responses in tissue engineering?
How do scaffolds influence cellular responses in tissue engineering?
Signup and view all the answers
What is the primary advantage of matrix-induced autologous chondrocyte implantation (MACI) over traditional cartilage repair methods?
What is the primary advantage of matrix-induced autologous chondrocyte implantation (MACI) over traditional cartilage repair methods?
Signup and view all the answers
Why is cartilage injury often asymptomatic initially?
Why is cartilage injury often asymptomatic initially?
Signup and view all the answers
How does the use of fibrin glue enhance the MACI procedure?
How does the use of fibrin glue enhance the MACI procedure?
Signup and view all the answers
What role do stem cells play in cellular engineering therapies like MACI?
What role do stem cells play in cellular engineering therapies like MACI?
Signup and view all the answers
What is the significance of developing tissue constructs in the field of cellular engineering?
What is the significance of developing tissue constructs in the field of cellular engineering?
Signup and view all the answers
How does the cost of cartilage injuries impact healthcare in Australia?
How does the cost of cartilage injuries impact healthcare in Australia?
Signup and view all the answers
What are the limits of current treatment options for cartilage damage?
What are the limits of current treatment options for cartilage damage?
Signup and view all the answers
In which joints is MACI currently being utilized, and what is its primary method of implantation?
In which joints is MACI currently being utilized, and what is its primary method of implantation?
Signup and view all the answers
What are the main advantages of using MACI for cartilage repair?
What are the main advantages of using MACI for cartilage repair?
Signup and view all the answers
What significant clinical outcomes have been observed from MACI within two years post-surgery?
What significant clinical outcomes have been observed from MACI within two years post-surgery?
Signup and view all the answers
How does MACI address the complications associated with microfracture techniques?
How does MACI address the complications associated with microfracture techniques?
Signup and view all the answers
What is the purpose of using a collagen membrane in the MACI procedure?
What is the purpose of using a collagen membrane in the MACI procedure?
Signup and view all the answers
Which aspects are considered challenges and innovations in current cartilage repair strategies?
Which aspects are considered challenges and innovations in current cartilage repair strategies?
Signup and view all the answers
What is the future goal for joint repair beyond cartilage repair with MACI?
What is the future goal for joint repair beyond cartilage repair with MACI?
Signup and view all the answers
Why is MACI considered an advancement over traditional autologous chondrocyte implantation (ACI)?
Why is MACI considered an advancement over traditional autologous chondrocyte implantation (ACI)?
Signup and view all the answers
What role do regulatory considerations play in the application of stem cell therapies?
What role do regulatory considerations play in the application of stem cell therapies?
Signup and view all the answers
How does the clinical application of MACI in Australasia compare to that in the USA?
How does the clinical application of MACI in Australasia compare to that in the USA?
Signup and view all the answers
What are key recommendations for clinicians when employing stem cell therapies?
What are key recommendations for clinicians when employing stem cell therapies?
Signup and view all the answers
What triggers the activation of hepatic non-parenchymal cells in liver disease?
What triggers the activation of hepatic non-parenchymal cells in liver disease?
Signup and view all the answers
Where do oval cells reside in the liver and what is their primary function?
Where do oval cells reside in the liver and what is their primary function?
Signup and view all the answers
What effect does transforming growth factor (TGF) have on hepatocyte DNA synthesis?
What effect does transforming growth factor (TGF) have on hepatocyte DNA synthesis?
Signup and view all the answers
How do hepatic progenitor cells (HPCs) contribute to liver regeneration?
How do hepatic progenitor cells (HPCs) contribute to liver regeneration?
Signup and view all the answers
What are some genetic liver diseases that can be treated using gene therapy?
What are some genetic liver diseases that can be treated using gene therapy?
Signup and view all the answers
What role do Kupffer cells play in the liver's immune response?
What role do Kupffer cells play in the liver's immune response?
Signup and view all the answers
What is the significance of isolating oval cells from the liver?
What is the significance of isolating oval cells from the liver?
Signup and view all the answers
Describe the contribution of hepatic stellate cells (HSCs) to liver pathology.
Describe the contribution of hepatic stellate cells (HSCs) to liver pathology.
Signup and view all the answers
What role do activated hepatic stellate cells (HSCs) play in liver fibrosis?
What role do activated hepatic stellate cells (HSCs) play in liver fibrosis?
Signup and view all the answers
How do mesenchymal stem cells (MSCs) contribute to the treatment of liver disease?
How do mesenchymal stem cells (MSCs) contribute to the treatment of liver disease?
Signup and view all the answers
What limitations exist when generating hepatocyte-like cells from pluripotent stem cells?
What limitations exist when generating hepatocyte-like cells from pluripotent stem cells?
Signup and view all the answers
What are liver organoids and what potential do they have?
What are liver organoids and what potential do they have?
Signup and view all the answers
What is the main challenge associated with using stem cell therapies for treating liver diseases?
What is the main challenge associated with using stem cell therapies for treating liver diseases?
Signup and view all the answers
What factors contribute to the activation of HSCs in the liver?
What factors contribute to the activation of HSCs in the liver?
Signup and view all the answers
Why are liver buds considered promising for transplantation?
Why are liver buds considered promising for transplantation?
Signup and view all the answers
What types of clinical trials have been conducted using MSCs for liver cirrhosis?
What types of clinical trials have been conducted using MSCs for liver cirrhosis?
Signup and view all the answers
How do small molecules aid in improving the function of hepatocyte-like cells?
How do small molecules aid in improving the function of hepatocyte-like cells?
Signup and view all the answers
What is a significant concern regarding the transplant of cells in regenerative medicine?
What is a significant concern regarding the transplant of cells in regenerative medicine?
Signup and view all the answers
What is the function of CRISPR/Cas9 in gene therapy?
What is the function of CRISPR/Cas9 in gene therapy?
Signup and view all the answers
How are induced pluripotent stem cells (iPSCs) generated?
How are induced pluripotent stem cells (iPSCs) generated?
Signup and view all the answers
What is the main challenge associated with liver transplantation?
What is the main challenge associated with liver transplantation?
Signup and view all the answers
What is the purpose of a Bio-Artificial Liver Device (ELAD)?
What is the purpose of a Bio-Artificial Liver Device (ELAD)?
Signup and view all the answers
What are the roles of mesenchymal stem cells (MSCs) in liver disease treatment?
What are the roles of mesenchymal stem cells (MSCs) in liver disease treatment?
Signup and view all the answers
What is Non-Alcoholic Steatohepatitis (NASH), and how does it differ from Non-Alcoholic Fatty Liver Disease (NAFLD)?
What is Non-Alcoholic Steatohepatitis (NASH), and how does it differ from Non-Alcoholic Fatty Liver Disease (NAFLD)?
Signup and view all the answers
What are the challenges facing hepatocyte transplantation as a treatment option?
What are the challenges facing hepatocyte transplantation as a treatment option?
Signup and view all the answers
How do viral vectors contribute to gene therapy?
How do viral vectors contribute to gene therapy?
Signup and view all the answers
What is the significance of using patient-specific iPSCs in gene therapy?
What is the significance of using patient-specific iPSCs in gene therapy?
Signup and view all the answers
What metabolic factors contribute to lifestyle-related liver diseases?
What metabolic factors contribute to lifestyle-related liver diseases?
Signup and view all the answers
How does the process of regenerative medicine apply to liver disease treatment?
How does the process of regenerative medicine apply to liver disease treatment?
Signup and view all the answers
What is the role of hepatic stellate cells (HSCs) in liver injury?
What is the role of hepatic stellate cells (HSCs) in liver injury?
Signup and view all the answers
What is the therapeutic approach using ex vivo gene therapy for genetic liver diseases?
What is the therapeutic approach using ex vivo gene therapy for genetic liver diseases?
Signup and view all the answers
What are the potential benefits of using immunotherapy in cancer treatment for liver disease?
What are the potential benefits of using immunotherapy in cancer treatment for liver disease?
Signup and view all the answers
What is the main consequence of fibrosis in affected tissues?
What is the main consequence of fibrosis in affected tissues?
Signup and view all the answers
How does the intrinsic cellular capacity influence tissue repair?
How does the intrinsic cellular capacity influence tissue repair?
Signup and view all the answers
What role does the location of injury play in the healing process?
What role does the location of injury play in the healing process?
Signup and view all the answers
What factors can delay the healing process in tissues?
What factors can delay the healing process in tissues?
Signup and view all the answers
Describe how stable cells differ from labile and permanent cells regarding injury response.
Describe how stable cells differ from labile and permanent cells regarding injury response.
Signup and view all the answers
What is the significance of the excessive scar tissue in the context of myocardial infarction?
What is the significance of the excessive scar tissue in the context of myocardial infarction?
Signup and view all the answers
How do chronic injuries affect the tissue repair process?
How do chronic injuries affect the tissue repair process?
Signup and view all the answers
What potential consequences arise from a prolonged injurious agent's exposure on tissue repair?
What potential consequences arise from a prolonged injurious agent's exposure on tissue repair?
Signup and view all the answers
What role do fibroblasts play in the development of fibrosis?
What role do fibroblasts play in the development of fibrosis?
Signup and view all the answers
Which signaling pathway is known to increase fibrosis in mouse models?
Which signaling pathway is known to increase fibrosis in mouse models?
Signup and view all the answers
What are some models used to investigate lung fibrosis?
What are some models used to investigate lung fibrosis?
Signup and view all the answers
How are small molecule inhibitors relevant to fibrosis research?
How are small molecule inhibitors relevant to fibrosis research?
Signup and view all the answers
What autoimmune-like features are present in idiopathic pulmonary fibrosis (IPF)?
What autoimmune-like features are present in idiopathic pulmonary fibrosis (IPF)?
Signup and view all the answers
What is the significance of the 'scar in a jar' model in fibrosis research?
What is the significance of the 'scar in a jar' model in fibrosis research?
Signup and view all the answers
What effect does the treatment targeting plasma cells have on lung fibrosis?
What effect does the treatment targeting plasma cells have on lung fibrosis?
Signup and view all the answers
What are the challenges in finding effective treatments for idiopathic pulmonary fibrosis?
What are the challenges in finding effective treatments for idiopathic pulmonary fibrosis?
Signup and view all the answers
How do immune cells contribute to the fibrosis process?
How do immune cells contribute to the fibrosis process?
Signup and view all the answers
What method is used to quantify fibrosis in mouse lung tissue?
What method is used to quantify fibrosis in mouse lung tissue?
Signup and view all the answers
How do systemic factors like diabetes influence wound healing?
How do systemic factors like diabetes influence wound healing?
Signup and view all the answers
What impact do steroids have on wound healing and scar formation?
What impact do steroids have on wound healing and scar formation?
Signup and view all the answers
What role do fibroblasts play in the formation of scar tissue?
What role do fibroblasts play in the formation of scar tissue?
Signup and view all the answers
What is described as a pathological response to injury characterized by excessive collagen deposition?
What is described as a pathological response to injury characterized by excessive collagen deposition?
Signup and view all the answers
How does the extracellular matrix (ECM) influence cellular behavior during tissue repair?
How does the extracellular matrix (ECM) influence cellular behavior during tissue repair?
Signup and view all the answers
What are the clinical implications of excessive collagen deposition in conditions like pulmonary fibrosis?
What are the clinical implications of excessive collagen deposition in conditions like pulmonary fibrosis?
Signup and view all the answers
What sequential processes occur during wound healing?
What sequential processes occur during wound healing?
Signup and view all the answers
How do foreign bodies affect the wound healing process?
How do foreign bodies affect the wound healing process?
Signup and view all the answers
What is the primary function of growth factors in tissue repair?
What is the primary function of growth factors in tissue repair?
Signup and view all the answers
What is the significance of collagen synthesis starting 3-5 days after injury?
What is the significance of collagen synthesis starting 3-5 days after injury?
Signup and view all the answers
Explain how mechanical stress affects wound healing.
Explain how mechanical stress affects wound healing.
Signup and view all the answers
What role do autocrine and paracrine signaling play in tissue repair?
What role do autocrine and paracrine signaling play in tissue repair?
Signup and view all the answers
What characteristics define idiopathic pulmonary fibrosis (IPF)?
What characteristics define idiopathic pulmonary fibrosis (IPF)?
Signup and view all the answers
How does the regulation of healing depend on signaling factors?
How does the regulation of healing depend on signaling factors?
Signup and view all the answers
What distinguishes the interstitial matrix from the basement membrane in ECM?
What distinguishes the interstitial matrix from the basement membrane in ECM?
Signup and view all the answers
What is the primary function of killer T cells in the immune system?
What is the primary function of killer T cells in the immune system?
Signup and view all the answers
Define 'tolerance' in the context of T cell immunity.
Define 'tolerance' in the context of T cell immunity.
Signup and view all the answers
What are the three types of dendritic cells mentioned?
What are the three types of dendritic cells mentioned?
Signup and view all the answers
How do dendritic cells contribute to cancer immunotherapy?
How do dendritic cells contribute to cancer immunotherapy?
Signup and view all the answers
What is cross-presentation in relation to dendritic cells?
What is cross-presentation in relation to dendritic cells?
Signup and view all the answers
What is the significance of stage 0 in melanoma development?
What is the significance of stage 0 in melanoma development?
Signup and view all the answers
Explain the importance of dendritic cells in maintaining immune homeostasis.
Explain the importance of dendritic cells in maintaining immune homeostasis.
Signup and view all the answers
What is an example of a study involving dendritic cells in skin cancer?
What is an example of a study involving dendritic cells in skin cancer?
Signup and view all the answers
What role do XCR1+ dendritic cells play in tumor immunity?
What role do XCR1+ dendritic cells play in tumor immunity?
Signup and view all the answers
How do tissue-resident memory T cells (TRM) contribute to controlling melanoma?
How do tissue-resident memory T cells (TRM) contribute to controlling melanoma?
Signup and view all the answers
What is the significance of the adoptive cell therapy approach?
What is the significance of the adoptive cell therapy approach?
Signup and view all the answers
Explain the importance of Flt3L in dendritic cell biology.
Explain the importance of Flt3L in dendritic cell biology.
Signup and view all the answers
What are the three phases of tumor interaction with the immune system?
What are the three phases of tumor interaction with the immune system?
Signup and view all the answers
What are the implications of tumor heterogeneity on cancer treatment?
What are the implications of tumor heterogeneity on cancer treatment?
Signup and view all the answers
What is the epicutaneous model of melanoma used for?
What is the epicutaneous model of melanoma used for?
Signup and view all the answers
How does the concept of immune equilibrium relate to melanoma?
How does the concept of immune equilibrium relate to melanoma?
Signup and view all the answers
What is the role of IL-10 and TGF-β in cytokine therapy for myoblasts?
What is the role of IL-10 and TGF-β in cytokine therapy for myoblasts?
Signup and view all the answers
How can bacterial vectors like pMP6a be used in cytokine therapy?
How can bacterial vectors like pMP6a be used in cytokine therapy?
Signup and view all the answers
Explain the process of in vivo electroporation in muscle tissue.
Explain the process of in vivo electroporation in muscle tissue.
Signup and view all the answers
What is the significance of using ampicillin resistance in bacterial selection?
What is the significance of using ampicillin resistance in bacterial selection?
Signup and view all the answers
Why is long-term gene expression critical in gene therapy?
Why is long-term gene expression critical in gene therapy?
Signup and view all the answers
What challenges remain in the field of gene therapy according to the key takeaways?
What challenges remain in the field of gene therapy according to the key takeaways?
Signup and view all the answers
Describe one advantage of non-viral methods of gene therapy.
Describe one advantage of non-viral methods of gene therapy.
Signup and view all the answers
How do cytokine levels relate to immune response in the context of muscle regeneration?
How do cytokine levels relate to immune response in the context of muscle regeneration?
Signup and view all the answers
What is gene therapy and what kind of diseases can it potentially treat?
What is gene therapy and what kind of diseases can it potentially treat?
Signup and view all the answers
Describe the process of normal gene insertion in gene therapy.
Describe the process of normal gene insertion in gene therapy.
Signup and view all the answers
How does homologous recombination facilitate gene therapy?
How does homologous recombination facilitate gene therapy?
Signup and view all the answers
What role do viral vectors play in gene therapy?
What role do viral vectors play in gene therapy?
Signup and view all the answers
Explain how gene repair functions in the context of gene therapy.
Explain how gene repair functions in the context of gene therapy.
Signup and view all the answers
What method is used to test the integration and expression of transfected genes in gene therapy?
What method is used to test the integration and expression of transfected genes in gene therapy?
Signup and view all the answers
What is gene regulation alteration in gene therapy?
What is gene regulation alteration in gene therapy?
Signup and view all the answers
What type of virus is commonly used in gene therapy and what is its characteristic?
What type of virus is commonly used in gene therapy and what is its characteristic?
Signup and view all the answers
What is the main advantage of adeno-associated viruses (AAVs) in gene therapy?
What is the main advantage of adeno-associated viruses (AAVs) in gene therapy?
Signup and view all the answers
Explain how retroviruses contribute to gene therapy.
Explain how retroviruses contribute to gene therapy.
Signup and view all the answers
What challenge do immune responses pose in myoblast transfer therapy for Duchenne Muscular Dystrophy (DMD)?
What challenge do immune responses pose in myoblast transfer therapy for Duchenne Muscular Dystrophy (DMD)?
Signup and view all the answers
How does the technique of exon skipping work in gene therapy for DMD?
How does the technique of exon skipping work in gene therapy for DMD?
Signup and view all the answers
What are the primary sources of genes delivered via non-viral methods?
What are the primary sources of genes delivered via non-viral methods?
Signup and view all the answers
Describe what DMD is and its primary cause.
Describe what DMD is and its primary cause.
Signup and view all the answers
What role do regulatory T cells (Tregs) play in gene therapy?
What role do regulatory T cells (Tregs) play in gene therapy?
Signup and view all the answers
Why are mini dystrophin genes utilized in gene therapy for DMD?
Why are mini dystrophin genes utilized in gene therapy for DMD?
Signup and view all the answers
Explain the significance of the dystrophin protein in muscle cells.
Explain the significance of the dystrophin protein in muscle cells.
Signup and view all the answers
How do non-viral delivery systems compare to viral ones in gene therapy?
How do non-viral delivery systems compare to viral ones in gene therapy?
Signup and view all the answers
What is unique about herpes simplex viruses in the context of gene therapy?
What is unique about herpes simplex viruses in the context of gene therapy?
Signup and view all the answers
What is the result of a nonsense mutation in the dystrophin gene?
What is the result of a nonsense mutation in the dystrophin gene?
Signup and view all the answers
Discuss a limitation of the direct injection method for gene delivery.
Discuss a limitation of the direct injection method for gene delivery.
Signup and view all the answers
What is gene therapy and how does it differ from traditional treatment methods?
What is gene therapy and how does it differ from traditional treatment methods?
Signup and view all the answers
Why are viral vectors used in gene therapy, and what is a common example?
Why are viral vectors used in gene therapy, and what is a common example?
Signup and view all the answers
List two reasons why the eye is considered an ideal target for gene therapy.
List two reasons why the eye is considered an ideal target for gene therapy.
Signup and view all the answers
What is the first key step in developing a gene therapy strategy?
What is the first key step in developing a gene therapy strategy?
Signup and view all the answers
What role do biological models play in gene therapy development?
What role do biological models play in gene therapy development?
Signup and view all the answers
How do the immune properties of the eye benefit ocular gene therapy?
How do the immune properties of the eye benefit ocular gene therapy?
Signup and view all the answers
What is the significance of selecting the correct vector in gene therapy?
What is the significance of selecting the correct vector in gene therapy?
Signup and view all the answers
What are the primary focuses during the initial clinical trials of gene therapy?
What are the primary focuses during the initial clinical trials of gene therapy?
Signup and view all the answers
What genetic mechanism leads to anticipation and severity increase in certain dominant disorders like Huntington's disease?
What genetic mechanism leads to anticipation and severity increase in certain dominant disorders like Huntington's disease?
Signup and view all the answers
How does gene replacement therapy differ from molecular therapies in treating genetic disorders?
How does gene replacement therapy differ from molecular therapies in treating genetic disorders?
Signup and view all the answers
What is the role of Antisense Oligonucleotides (AOs) in treating genetic diseases?
What is the role of Antisense Oligonucleotides (AOs) in treating genetic diseases?
Signup and view all the answers
What challenges do rare diseases present in terms of treatment availability?
What challenges do rare diseases present in terms of treatment availability?
Signup and view all the answers
What is the significance of dystrophin in muscular dystrophies such as Duchenne Muscular Dystrophy (DMD)?
What is the significance of dystrophin in muscular dystrophies such as Duchenne Muscular Dystrophy (DMD)?
Signup and view all the answers
How do frame-shifting mutations in the dystrophin gene contribute to DMD?
How do frame-shifting mutations in the dystrophin gene contribute to DMD?
Signup and view all the answers
What is the role of SMN1 gene in Spinal Muscular Atrophy (SMA)?
What is the role of SMN1 gene in Spinal Muscular Atrophy (SMA)?
Signup and view all the answers
In the context of muscular dystrophies, how does the presence of some dystrophin impact disease severity?
In the context of muscular dystrophies, how does the presence of some dystrophin impact disease severity?
Signup and view all the answers
What therapeutic approach was approved by the FDA for treating DMD in 2016, and how does it work?
What therapeutic approach was approved by the FDA for treating DMD in 2016, and how does it work?
Signup and view all the answers
How do infections and organ failure relate to complications in muscle degenerative disorders?
How do infections and organ failure relate to complications in muscle degenerative disorders?
Signup and view all the answers
What demographic changes are influencing the prevalence of rare diseases across different regions of the world?
What demographic changes are influencing the prevalence of rare diseases across different regions of the world?
Signup and view all the answers
What is the significance of the creatine kinase levels in assessing muscle damage in dystrophinopathies?
What is the significance of the creatine kinase levels in assessing muscle damage in dystrophinopathies?
Signup and view all the answers
What role do satellite cells play in muscle repair following damage in muscular dystrophies?
What role do satellite cells play in muscle repair following damage in muscular dystrophies?
Signup and view all the answers
What outcomes are associated with the use of gene therapy in treating Retinitis Pigmentosa?
What outcomes are associated with the use of gene therapy in treating Retinitis Pigmentosa?
Signup and view all the answers
What is the primary advantage of subretinal injection compared to intravitreal injection in gene therapy?
What is the primary advantage of subretinal injection compared to intravitreal injection in gene therapy?
Signup and view all the answers
Why is AAV considered effective for gene delivery in both dividing and non-dividing cells?
Why is AAV considered effective for gene delivery in both dividing and non-dividing cells?
Signup and view all the answers
What are the potential risks associated with the creation of a local bleb during subretinal injection?
What are the potential risks associated with the creation of a local bleb during subretinal injection?
Signup and view all the answers
Identify one challenge that gene therapy faces regarding AAV's genome packaging capacity.
Identify one challenge that gene therapy faces regarding AAV's genome packaging capacity.
Signup and view all the answers
How does pre-existing immunity affect the effectiveness of AAV-based gene therapy?
How does pre-existing immunity affect the effectiveness of AAV-based gene therapy?
Signup and view all the answers
What role does alternative splicing play in gene expression?
What role does alternative splicing play in gene expression?
Signup and view all the answers
Which specific cells are effectively targeted by AAV2, AAV8, and AAV9 in the retina?
Which specific cells are effectively targeted by AAV2, AAV8, and AAV9 in the retina?
Signup and view all the answers
What is the significance of RPE65 gene therapy for Leber Congenital Amaurosis?
What is the significance of RPE65 gene therapy for Leber Congenital Amaurosis?
Signup and view all the answers
In the context of Age-Related Macular Degeneration (AMD), what therapeutic approach is being developed using AAV vectors?
In the context of Age-Related Macular Degeneration (AMD), what therapeutic approach is being developed using AAV vectors?
Signup and view all the answers
What problems can arise from the delivery method chosen for gene therapy, such as subretinal vs. intravitreal injection?
What problems can arise from the delivery method chosen for gene therapy, such as subretinal vs. intravitreal injection?
Signup and view all the answers
What recent advancements are being explored in ongoing trials for ocular conditions using AAV-based therapies?
What recent advancements are being explored in ongoing trials for ocular conditions using AAV-based therapies?
Signup and view all the answers
Describe one way splicing disruptions can contribute to disease development.
Describe one way splicing disruptions can contribute to disease development.
Signup and view all the answers
What can be inferred about the role of AAV's low immunogenicity in gene therapy?
What can be inferred about the role of AAV's low immunogenicity in gene therapy?
Signup and view all the answers
What is the impact of mutations on gene function in the context of missense and nonsense mutations?
What is the impact of mutations on gene function in the context of missense and nonsense mutations?
Signup and view all the answers
What therapeutic target does gene therapy aim to influence in the case of genetic defects?
What therapeutic target does gene therapy aim to influence in the case of genetic defects?
Signup and view all the answers
What does CRISPR stand for and what is its primary function in bacteria?
What does CRISPR stand for and what is its primary function in bacteria?
Signup and view all the answers
What role does the PAM sequence play in the CRISPR-Cas9 system?
What role does the PAM sequence play in the CRISPR-Cas9 system?
Signup and view all the answers
Describe the function of guide RNA (gRNA) in the CRISPR-Cas9 system.
Describe the function of guide RNA (gRNA) in the CRISPR-Cas9 system.
Signup and view all the answers
What are the differences in delivery methods for CRISPR components, and why are they significant?
What are the differences in delivery methods for CRISPR components, and why are they significant?
Signup and view all the answers
Explain how the CRISPR system allows bacteria to defend against viral infections.
Explain how the CRISPR system allows bacteria to defend against viral infections.
Signup and view all the answers
What is the significance of the Cas9 protein in gene editing?
What is the significance of the Cas9 protein in gene editing?
Signup and view all the answers
Identify one limitation of CRISPR technology in clinical applications.
Identify one limitation of CRISPR technology in clinical applications.
Signup and view all the answers
What role do spacers play in the CRISPR system?
What role do spacers play in the CRISPR system?
Signup and view all the answers
What are the two main pathways for repairing DNA damage in eukaryotic cells, and how do they differ?
What are the two main pathways for repairing DNA damage in eukaryotic cells, and how do they differ?
Signup and view all the answers
How does the timing of DNA repair processes differ between NHEJ and HDR?
How does the timing of DNA repair processes differ between NHEJ and HDR?
Signup and view all the answers
What is one advantage and disadvantage of using plasmids for CRISPR components delivery?
What is one advantage and disadvantage of using plasmids for CRISPR components delivery?
Signup and view all the answers
What are Ribonucleoprotein Complexes (RNPs), and how do they differ from plasmids in CRISPR applications?
What are Ribonucleoprotein Complexes (RNPs), and how do they differ from plasmids in CRISPR applications?
Signup and view all the answers
What role does dCas9 play in gene manipulation?
What role does dCas9 play in gene manipulation?
Signup and view all the answers
How can CRISPR be utilized to study the function of new genes?
How can CRISPR be utilized to study the function of new genes?
Signup and view all the answers
What is the main challenge associated with editing high turnover rate cells in vivo?
What is the main challenge associated with editing high turnover rate cells in vivo?
Signup and view all the answers
Describe a therapeutic potential of CRISPR for monogenic diseases.
Describe a therapeutic potential of CRISPR for monogenic diseases.
Signup and view all the answers
What is the significance of using iPSCs in CRISPR-based therapies?
What is the significance of using iPSCs in CRISPR-based therapies?
Signup and view all the answers
What common mutation causes cystic fibrosis, and what impact does it have?
What common mutation causes cystic fibrosis, and what impact does it have?
Signup and view all the answers
Identify one method that can improve the specificity of nanoparticle delivery in CRISPR applications.
Identify one method that can improve the specificity of nanoparticle delivery in CRISPR applications.
Signup and view all the answers
What is a primary advantage of using nanoparticle delivery systems for CRISPR?
What is a primary advantage of using nanoparticle delivery systems for CRISPR?
Signup and view all the answers
What ethical considerations arise in the context of CRISPR technology?
What ethical considerations arise in the context of CRISPR technology?
Signup and view all the answers
What complicates gene therapy for most common diseases?
What complicates gene therapy for most common diseases?
Signup and view all the answers
What is a major challenge regarding the efficacy of gene therapy in non-stem cells?
What is a major challenge regarding the efficacy of gene therapy in non-stem cells?
Signup and view all the answers
How can gene therapy lead to unwanted effects in the genome?
How can gene therapy lead to unwanted effects in the genome?
Signup and view all the answers
What issues are associated with the use of vectors in gene therapy?
What issues are associated with the use of vectors in gene therapy?
Signup and view all the answers
What are the implications of immune responses in repeated gene therapy treatments?
What are the implications of immune responses in repeated gene therapy treatments?
Signup and view all the answers
What is the primary function of the Cas9 enzyme in the CRISPR system?
What is the primary function of the Cas9 enzyme in the CRISPR system?
Signup and view all the answers
What role do PAM sequences play in the CRISPR-Cas9 system?
What role do PAM sequences play in the CRISPR-Cas9 system?
Signup and view all the answers
What are the two main pathways for gene editing using CRISPR-Cas9?
What are the two main pathways for gene editing using CRISPR-Cas9?
Signup and view all the answers
How do base editors improve the CRISPR technology?
How do base editors improve the CRISPR technology?
Signup and view all the answers
What is one therapeutic example where CRISPR-Cas9 has potential benefits?
What is one therapeutic example where CRISPR-Cas9 has potential benefits?
Signup and view all the answers
What are some limitations of CRISPR technology in clinical applications?
What are some limitations of CRISPR technology in clinical applications?
Signup and view all the answers
What is the primary source of spacers in the CRISPR system?
What is the primary source of spacers in the CRISPR system?
Signup and view all the answers
What distinguishes the Type I and II systems in CRISPR?
What distinguishes the Type I and II systems in CRISPR?
Signup and view all the answers
What are the two main repair pathways used by eukaryotic cells after DNA cleavage induced by CRISPR?
What are the two main repair pathways used by eukaryotic cells after DNA cleavage induced by CRISPR?
Signup and view all the answers
What is the significance of the protospacer adjacent motif (PAM) in CRISPR technology?
What is the significance of the protospacer adjacent motif (PAM) in CRISPR technology?
Signup and view all the answers
How does the use of dead Cas9 (dCas9) differ from active Cas9 in CRISPR applications?
How does the use of dead Cas9 (dCas9) differ from active Cas9 in CRISPR applications?
Signup and view all the answers
What are some common delivery methods for CRISPR components to cells?
What are some common delivery methods for CRISPR components to cells?
Signup and view all the answers
In CRISPR therapy, what advantage does using ribonucleoprotein (RNP) complexes have over plasmids?
In CRISPR therapy, what advantage does using ribonucleoprotein (RNP) complexes have over plasmids?
Signup and view all the answers
Why are induced pluripotent stem cells (iPSCs) considered valuable for gene therapy?
Why are induced pluripotent stem cells (iPSCs) considered valuable for gene therapy?
Signup and view all the answers
What outcomes can CRISPR be used to achieve in gene manipulation?
What outcomes can CRISPR be used to achieve in gene manipulation?
Signup and view all the answers
What challenges are associated with editing cells in vivo compared to in vitro?
What challenges are associated with editing cells in vivo compared to in vitro?
Signup and view all the answers
How does the effectiveness of Non-Homologous End Joining (NHEJ) compare to Homology Directed Repair (HDR)?
How does the effectiveness of Non-Homologous End Joining (NHEJ) compare to Homology Directed Repair (HDR)?
Signup and view all the answers
What role do nanoparticle deliveries, such as CRISPR Gold, play in CRISPR applications?
What role do nanoparticle deliveries, such as CRISPR Gold, play in CRISPR applications?
Signup and view all the answers
What mutation causes Hemophilia B, and what main factor is affected in the blood coagulation cascade?
What mutation causes Hemophilia B, and what main factor is affected in the blood coagulation cascade?
Signup and view all the answers
What type of viral vector showed promise for long-term phenotypic correction of Hemophilia B in mice?
What type of viral vector showed promise for long-term phenotypic correction of Hemophilia B in mice?
Signup and view all the answers
What are the limitations associated with current CRISPR-based gene editing therapies?
What are the limitations associated with current CRISPR-based gene editing therapies?
Signup and view all the answers
What is the primary therapeutic strategy currently used to manage HIV/AIDS?
What is the primary therapeutic strategy currently used to manage HIV/AIDS?
Signup and view all the answers
How did the first CRISPR attempt to cure HIV infection, published in September 2019, function?
How did the first CRISPR attempt to cure HIV infection, published in September 2019, function?
Signup and view all the answers
What challenge remains after stopping HAART in HIV patients?
What challenge remains after stopping HAART in HIV patients?
Signup and view all the answers
What is the significance of using AAV vectors in gene therapy for Hemophilia B?
What is the significance of using AAV vectors in gene therapy for Hemophilia B?
Signup and view all the answers
What type of genetic editing technology was first applied to prevent HIV-1 infection in 2013?
What type of genetic editing technology was first applied to prevent HIV-1 infection in 2013?
Signup and view all the answers
Why is the delivery method a key limitation in CRISPR gene editing?
Why is the delivery method a key limitation in CRISPR gene editing?
Signup and view all the answers
What evidence supports the safety and feasibility of CRISPR technology observed in clinical trials?
What evidence supports the safety and feasibility of CRISPR technology observed in clinical trials?
Signup and view all the answers
What ethical concerns are associated with CRISPR technology?
What ethical concerns are associated with CRISPR technology?
Signup and view all the answers
What was identified as a significant barrier to the widespread use of CRISPR therapies?
What was identified as a significant barrier to the widespread use of CRISPR therapies?
Signup and view all the answers
What role does the monogenic nature of Hemophilia B play in gene therapy research?
What role does the monogenic nature of Hemophilia B play in gene therapy research?
Signup and view all the answers
What is the primary genetic cause of Cystic Fibrosis (CF)?
What is the primary genetic cause of Cystic Fibrosis (CF)?
Signup and view all the answers
What major challenge exists in the gene therapy for Cystic Fibrosis?
What major challenge exists in the gene therapy for Cystic Fibrosis?
Signup and view all the answers
What genetic alteration is responsible for Sickle Cell Disease (SCD)?
What genetic alteration is responsible for Sickle Cell Disease (SCD)?
Signup and view all the answers
What is the role of BCL11A in treating Sickle Cell Disease?
What is the role of BCL11A in treating Sickle Cell Disease?
Signup and view all the answers
What notable achievement was reached with Casgevy, a CRISPR-based therapy?
What notable achievement was reached with Casgevy, a CRISPR-based therapy?
Signup and view all the answers
How does increasing fetal hemoglobin (HbF) levels affect patients with SCD or TDT?
How does increasing fetal hemoglobin (HbF) levels affect patients with SCD or TDT?
Signup and view all the answers
What is Duchenne Muscular Dystrophy (DMD) primarily caused by?
What is Duchenne Muscular Dystrophy (DMD) primarily caused by?
Signup and view all the answers
What innovative technique has been used to correct the dystrophin gene in DMD patients?
What innovative technique has been used to correct the dystrophin gene in DMD patients?
Signup and view all the answers
What is a significant benefit of gene therapies like those developed for CF or SCD?
What is a significant benefit of gene therapies like those developed for CF or SCD?
Signup and view all the answers
What therapeutic strategy has been highlighted for ameliorating symptoms of Sickle Cell Disease?
What therapeutic strategy has been highlighted for ameliorating symptoms of Sickle Cell Disease?
Signup and view all the answers
What was the patient response in terms of transfusion independence after the Casgevy treatment?
What was the patient response in terms of transfusion independence after the Casgevy treatment?
Signup and view all the answers
What kind of mutations lead to ineffective red blood cell development in TDT?
What kind of mutations lead to ineffective red blood cell development in TDT?
Signup and view all the answers
What is 'hereditary persistence of fetal hemoglobin' (HPFH) and its significance?
What is 'hereditary persistence of fetal hemoglobin' (HPFH) and its significance?
Signup and view all the answers
How does CRISPR-mediated gene editing impact patients with SCD or TDT?
How does CRISPR-mediated gene editing impact patients with SCD or TDT?
Signup and view all the answers
What are the main components of allorecognition during transplant rejection?
What are the main components of allorecognition during transplant rejection?
Signup and view all the answers
What is the difference between homologous and heterologous transplants?
What is the difference between homologous and heterologous transplants?
Signup and view all the answers
Which types of cells primarily express HLA class II molecules?
Which types of cells primarily express HLA class II molecules?
Signup and view all the answers
Why is HLA matching important in transplantation?
Why is HLA matching important in transplantation?
Signup and view all the answers
What role do CD8 T cells play in the immune response during acute rejection of a transplant?
What role do CD8 T cells play in the immune response during acute rejection of a transplant?
Signup and view all the answers
How does HLA diversity affect transplantation success in different populations?
How does HLA diversity affect transplantation success in different populations?
Signup and view all the answers
What types of biological materials can be transplanted besides solid organs?
What types of biological materials can be transplanted besides solid organs?
Signup and view all the answers
What is the primary function of Major Histocompatibility Complex (MHC) molecules in adaptive immunity?
What is the primary function of Major Histocompatibility Complex (MHC) molecules in adaptive immunity?
Signup and view all the answers
What role do HLA mismatched molecules play in transplant rejection?
What role do HLA mismatched molecules play in transplant rejection?
Signup and view all the answers
Name the type of rejection that occurs due to preformed ABO isohaemogglutinins.
Name the type of rejection that occurs due to preformed ABO isohaemogglutinins.
Signup and view all the answers
What is a key predictor of transplant outcome related to HLA matching?
What is a key predictor of transplant outcome related to HLA matching?
Signup and view all the answers
Describe the general consequences of acute rejection in renal allografts.
Describe the general consequences of acute rejection in renal allografts.
Signup and view all the answers
What are the long-term changes associated with chronic rejection of kidney transplants?
What are the long-term changes associated with chronic rejection of kidney transplants?
Signup and view all the answers
How does a positive crossmatch test influence organ donation?
How does a positive crossmatch test influence organ donation?
Signup and view all the answers
What factors are considered in the Australian National Organ Matching Program for kidney allocation?
What factors are considered in the Australian National Organ Matching Program for kidney allocation?
Signup and view all the answers
What is the effect of repeated HLA mismatches on transplant outcomes?
What is the effect of repeated HLA mismatches on transplant outcomes?
Signup and view all the answers
What complications may arise from the use of immunosuppressive drugs post-transplant?
What complications may arise from the use of immunosuppressive drugs post-transplant?
Signup and view all the answers
Identify a significant impact of HLA-DR mismatching in transplant patients.
Identify a significant impact of HLA-DR mismatching in transplant patients.
Signup and view all the answers
What solution is used to perfuse organs until they become transparent during retrieval?
What solution is used to perfuse organs until they become transparent during retrieval?
Signup and view all the answers
What is the maximum acceptable warm ischemic time (WIT) for liver donation?
What is the maximum acceptable warm ischemic time (WIT) for liver donation?
Signup and view all the answers
What should be done if a donor kidney is too small for transplantation?
What should be done if a donor kidney is too small for transplantation?
Signup and view all the answers
Why are cardiac donors typically less preferred for liver transplant?
Why are cardiac donors typically less preferred for liver transplant?
Signup and view all the answers
What is the purpose of using argon during the blood vessel sealing in liver transplantation?
What is the purpose of using argon during the blood vessel sealing in liver transplantation?
Signup and view all the answers
What device is used to elevate the ribcage if the transplanted liver is too large?
What device is used to elevate the ribcage if the transplanted liver is too large?
Signup and view all the answers
What is the preferred cold ischemic time (CIT) for a liver transplant, and why is it important?
What is the preferred cold ischemic time (CIT) for a liver transplant, and why is it important?
Signup and view all the answers
When preparing organs for transport, what are the three layers of packaging typically used?
When preparing organs for transport, what are the three layers of packaging typically used?
Signup and view all the answers
Identify two common causes of death that lead to organ donation.
Identify two common causes of death that lead to organ donation.
Signup and view all the answers
What is the purpose of using UW solution in liver perfusion?
What is the purpose of using UW solution in liver perfusion?
Signup and view all the answers
What anatomical structures must be reconstructed along with a liver transplant?
What anatomical structures must be reconstructed along with a liver transplant?
Signup and view all the answers
What problem is addressed by performing a cavaplasty when the recipient inferior vena cava (IVC) is damaged?
What problem is addressed by performing a cavaplasty when the recipient inferior vena cava (IVC) is damaged?
Signup and view all the answers
What anatomical structures are assessed to ensure successful liver transplantation?
What anatomical structures are assessed to ensure successful liver transplantation?
Signup and view all the answers
How is portal vein thrombosis typically managed during organ transplantation?
How is portal vein thrombosis typically managed during organ transplantation?
Signup and view all the answers
What is the significance of the bile in the gallbladder during the organ donation process?
What is the significance of the bile in the gallbladder during the organ donation process?
Signup and view all the answers
Describe the ‘marginal liver’ and its implications for liver transplants.
Describe the ‘marginal liver’ and its implications for liver transplants.
Signup and view all the answers
What legal requirements must be met for organ donation under the Human Tissue and Transplant Act 1982?
What legal requirements must be met for organ donation under the Human Tissue and Transplant Act 1982?
Signup and view all the answers
What are the two conditions that establish a definition of death according to the guidelines?
What are the two conditions that establish a definition of death according to the guidelines?
Signup and view all the answers
Identify two common causes of brain death in potential organ donors.
Identify two common causes of brain death in potential organ donors.
Signup and view all the answers
What is the importance of having two medical practitioners certifying death in the context of organ donation?
What is the importance of having two medical practitioners certifying death in the context of organ donation?
Signup and view all the answers
What roles do designated officers play in the organ donation process?
What roles do designated officers play in the organ donation process?
Signup and view all the answers
What are the two main methods to certify brain death?
What are the two main methods to certify brain death?
Signup and view all the answers
What is required for the certification of brain death?
What is required for the certification of brain death?
Signup and view all the answers
What is the process involved in Donation after Circulatory Death (DCDD)?
What is the process involved in Donation after Circulatory Death (DCDD)?
Signup and view all the answers
What factors determine whether organs can be donated?
What factors determine whether organs can be donated?
Signup and view all the answers
What does the decision to withdraw cardiorespiratory support (WCRS) entail?
What does the decision to withdraw cardiorespiratory support (WCRS) entail?
Signup and view all the answers
What is the primary focus of Family Donor Conversations (FDC)?
What is the primary focus of Family Donor Conversations (FDC)?
Signup and view all the answers
How is organ donor eligibility assessed?
How is organ donor eligibility assessed?
Signup and view all the answers
What is the significance of the Designated Officer in organ donation in WA?
What is the significance of the Designated Officer in organ donation in WA?
Signup and view all the answers
What is the difference between neurological death and circulatory death?
What is the difference between neurological death and circulatory death?
Signup and view all the answers
What are some conditions that warrant consideration for DCDD?
What are some conditions that warrant consideration for DCDD?
Signup and view all the answers
What role does consent play in organ donation?
What role does consent play in organ donation?
Signup and view all the answers
Why must families be approached for organ donation in an informed manner?
Why must families be approached for organ donation in an informed manner?
Signup and view all the answers
What happens if a death is referred to the coroner?
What happens if a death is referred to the coroner?
Signup and view all the answers
What criteria can affect organ allocation in transplants?
What criteria can affect organ allocation in transplants?
Signup and view all the answers
What is a significant aspect of the operating theatre during organ donation?
What is a significant aspect of the operating theatre during organ donation?
Signup and view all the answers
What constitutes the logistics of organ donation?
What constitutes the logistics of organ donation?
Signup and view all the answers
What are the two primary components of bone morphology?
What are the two primary components of bone morphology?
Signup and view all the answers
How do osteoblasts and osteoclasts contribute to bone remodelling?
How do osteoblasts and osteoclasts contribute to bone remodelling?
Signup and view all the answers
What is the significance of BMPs in osteogenesis?
What is the significance of BMPs in osteogenesis?
Signup and view all the answers
List two ideal properties of bone substitutes.
List two ideal properties of bone substitutes.
Signup and view all the answers
What role does autograft play in bone regeneration?
What role does autograft play in bone regeneration?
Signup and view all the answers
What are the two forms of osteoinduction and their importance?
What are the two forms of osteoinduction and their importance?
Signup and view all the answers
What impact does the surface area of a bone graft have on osteoconduction?
What impact does the surface area of a bone graft have on osteoconduction?
Signup and view all the answers
What is the difference between cancellous and cortical bone in terms of grafting?
What is the difference between cancellous and cortical bone in terms of grafting?
Signup and view all the answers
What is the primary difference between DBM and OP-1 in terms of their use as graft options?
What is the primary difference between DBM and OP-1 in terms of their use as graft options?
Signup and view all the answers
In what context is xenograft usage most commonly seen?
In what context is xenograft usage most commonly seen?
Signup and view all the answers
What is the significance of PlusLife's donor programs?
What is the significance of PlusLife's donor programs?
Signup and view all the answers
What specific regulations must PlusLife adhere to in their processing facilities?
What specific regulations must PlusLife adhere to in their processing facilities?
Signup and view all the answers
Describe the purpose of microbial testing in tissue processing.
Describe the purpose of microbial testing in tissue processing.
Signup and view all the answers
What is a major challenge associated with using coralline hydroxyapatite in grafting techniques?
What is a major challenge associated with using coralline hydroxyapatite in grafting techniques?
Signup and view all the answers
What are the exclusion criteria during donor screening for tissue donation?
What are the exclusion criteria during donor screening for tissue donation?
Signup and view all the answers
How does terminal irradiation contribute to the safety of grafts?
How does terminal irradiation contribute to the safety of grafts?
Signup and view all the answers
What role does the Cleanroom environment play in tissue processing?
What role does the Cleanroom environment play in tissue processing?
Signup and view all the answers
What type of graft is indicated for periprosthetic fractures?
What type of graft is indicated for periprosthetic fractures?
Signup and view all the answers
What defines an allograft and provide two examples of commonly transplanted allografts?
What defines an allograft and provide two examples of commonly transplanted allografts?
Signup and view all the answers
What are the two primary modes of transmission for allograft-transmissible infections?
What are the two primary modes of transmission for allograft-transmissible infections?
Signup and view all the answers
Explain the concept of lookback (or traceback) in allograft transmission.
Explain the concept of lookback (or traceback) in allograft transmission.
Signup and view all the answers
How might the presence of infections like HIV, HBV, or HCV in a donor not necessarily contraindicate donation?
How might the presence of infections like HIV, HBV, or HCV in a donor not necessarily contraindicate donation?
Signup and view all the answers
What is the significance of understanding transmissibility criteria for allograft-transmissible agents?
What is the significance of understanding transmissibility criteria for allograft-transmissible agents?
Signup and view all the answers
What is the primary purpose of biovigilance in the context of biological product safety?
What is the primary purpose of biovigilance in the context of biological product safety?
Signup and view all the answers
Explain the term 'window period' in relation to infectious disease screening.
Explain the term 'window period' in relation to infectious disease screening.
Signup and view all the answers
What does the 'healthy donor effect' imply in blood donation studies?
What does the 'healthy donor effect' imply in blood donation studies?
Signup and view all the answers
What factors influence the risk tolerability of allografts?
What factors influence the risk tolerability of allografts?
Signup and view all the answers
Why is donor selection critical in the context of allograft transplantation?
Why is donor selection critical in the context of allograft transplantation?
Signup and view all the answers
How does globalization impact the risks associated with allograft transmission?
How does globalization impact the risks associated with allograft transmission?
Signup and view all the answers
What role does education play in the donor screening process?
What role does education play in the donor screening process?
Signup and view all the answers
What are the consequences of not addressing residual risks in allograft transmission?
What are the consequences of not addressing residual risks in allograft transmission?
Signup and view all the answers
Explain how effective treatments contribute to the decreasing risk associated with allografts.
Explain how effective treatments contribute to the decreasing risk associated with allografts.
Signup and view all the answers
Why is precise HLA matching crucial for bone marrow donations?
Why is precise HLA matching crucial for bone marrow donations?
Signup and view all the answers
How does the availability of blood differ from organs in terms of transplantation?
How does the availability of blood differ from organs in terms of transplantation?
Signup and view all the answers
What is the importance of traceability in biovigilance?
What is the importance of traceability in biovigilance?
Signup and view all the answers
What underlying issues contribute to vaccine hesitancy affecting allograft safety?
What underlying issues contribute to vaccine hesitancy affecting allograft safety?
Signup and view all the answers
In terms of risk competency, what are the challenges faced during donor screening?
In terms of risk competency, what are the challenges faced during donor screening?
Signup and view all the answers
What criteria must products meet to receive RMAT designation from the FDA?
What criteria must products meet to receive RMAT designation from the FDA?
Signup and view all the answers
How does MiMedx's AmnioFix Injectable address an unmet medical need?
How does MiMedx's AmnioFix Injectable address an unmet medical need?
Signup and view all the answers
What constitutes a therapeutic good according to its definition?
What constitutes a therapeutic good according to its definition?
Signup and view all the answers
How can the classification of garlic change depending on its form and claims?
How can the classification of garlic change depending on its form and claims?
Signup and view all the answers
Explain the significance of the 'pathway of innovation' in product approval.
Explain the significance of the 'pathway of innovation' in product approval.
Signup and view all the answers
What makes Ortho-ATI's approach to RMAT designation similar to that of AmnioFix Injectable?
What makes Ortho-ATI's approach to RMAT designation similar to that of AmnioFix Injectable?
Signup and view all the answers
What regulatory authority oversees the standard for foods in Australia?
What regulatory authority oversees the standard for foods in Australia?
Signup and view all the answers
Why is scientific excellence alone insufficient for regulatory approval in the context of RMAT?
Why is scientific excellence alone insufficient for regulatory approval in the context of RMAT?
Signup and view all the answers
What is a key factor that determines whether a product is classified as a cosmetic or a therapeutic good?
What is a key factor that determines whether a product is classified as a cosmetic or a therapeutic good?
Signup and view all the answers
What types of goods are explicitly excluded from regulation as therapeutic goods?
What types of goods are explicitly excluded from regulation as therapeutic goods?
Signup and view all the answers
In the context of therapeutic goods, why is the method of administration significant?
In the context of therapeutic goods, why is the method of administration significant?
Signup and view all the answers
Why might a moisturizer be classified as a therapeutic good?
Why might a moisturizer be classified as a therapeutic good?
Signup and view all the answers
What legislative act provides the legal definition of therapeutic goods in Australia?
What legislative act provides the legal definition of therapeutic goods in Australia?
Signup and view all the answers
What main issues are considered to determine if a product is a 'therapeutic good'?
What main issues are considered to determine if a product is a 'therapeutic good'?
Signup and view all the answers
Why is regulation of therapeutic goods important, referencing thalidomide?
Why is regulation of therapeutic goods important, referencing thalidomide?
Signup and view all the answers
Who is responsible for regulating therapeutic goods in Australia?
Who is responsible for regulating therapeutic goods in Australia?
Signup and view all the answers
What essential data is reviewed during the pre-market evaluation of biotherapeutic products?
What essential data is reviewed during the pre-market evaluation of biotherapeutic products?
Signup and view all the answers
List two components of safety data evaluated in pre-market evaluation.
List two components of safety data evaluated in pre-market evaluation.
Signup and view all the answers
What are the three major categories of therapeutic goods?
What are the three major categories of therapeutic goods?
Signup and view all the answers
What is RMAT Designation and its significance?
What is RMAT Designation and its significance?
Signup and view all the answers
How is the safety of therapeutic goods monitored after they enter the market?
How is the safety of therapeutic goods monitored after they enter the market?
Signup and view all the answers
What role does the Excluded Goods Order play in regulating therapeutic goods?
What role does the Excluded Goods Order play in regulating therapeutic goods?
Signup and view all the answers
Identify one key criterion for a drug to receive RMAT Designation.
Identify one key criterion for a drug to receive RMAT Designation.
Signup and view all the answers
In what scenario might a biotherapeutic product be excluded from regulation?
In what scenario might a biotherapeutic product be excluded from regulation?
Signup and view all the answers
What are 'unmet medical needs' as defined by the FDA?
What are 'unmet medical needs' as defined by the FDA?
Signup and view all the answers
Name one problem associated with one-size-fits-all stem cell clinics.
Name one problem associated with one-size-fits-all stem cell clinics.
Signup and view all the answers
What are the core pillars of the regulation of therapeutic goods?
What are the core pillars of the regulation of therapeutic goods?
Signup and view all the answers
What kind of manufacturing data is crucial during the pre-market evaluation?
What kind of manufacturing data is crucial during the pre-market evaluation?
Signup and view all the answers
What is the significance of classifying a therapeutic product correctly?
What is the significance of classifying a therapeutic product correctly?
Signup and view all the answers
Why is donor evaluation critical in the production of biotherapeutic products?
Why is donor evaluation critical in the production of biotherapeutic products?
Signup and view all the answers
How does the TGA support the regulation of therapeutic goods?
How does the TGA support the regulation of therapeutic goods?
Signup and view all the answers
What was a significant financial implication related to the drug Vioxx?
What was a significant financial implication related to the drug Vioxx?
Signup and view all the answers
What does non-clinical safety data include in the pre-market evaluation?
What does non-clinical safety data include in the pre-market evaluation?
Signup and view all the answers
What type of regulatory oversight do biotherapeutic products typically require?
What type of regulatory oversight do biotherapeutic products typically require?
Signup and view all the answers
Describe the significance of traceability in biotherapeutic products.
Describe the significance of traceability in biotherapeutic products.
Signup and view all the answers
What impact did unapproved stem cell therapies have on the reputation of stem cell research?
What impact did unapproved stem cell therapies have on the reputation of stem cell research?
Signup and view all the answers
Why is it important for consumers to have timely access to therapeutic goods?
Why is it important for consumers to have timely access to therapeutic goods?
Signup and view all the answers
Identify one type of medical device mentioned in the context of therapeutic goods.
Identify one type of medical device mentioned in the context of therapeutic goods.
Signup and view all the answers
What are critical manufacturing steps in the context of biotherapeutic products?
What are critical manufacturing steps in the context of biotherapeutic products?
Signup and view all the answers
What is a significant characteristic of medicines under the regulatory framework?
What is a significant characteristic of medicines under the regulatory framework?
Signup and view all the answers
Why is long-term outcome data important for FDA approval?
Why is long-term outcome data important for FDA approval?
Signup and view all the answers
Explain one reason why the evaluation of biotherapeutic products is complex.
Explain one reason why the evaluation of biotherapeutic products is complex.
Signup and view all the answers
How does pharmacovigilance contribute to the safety of biotherapeutic products?
How does pharmacovigilance contribute to the safety of biotherapeutic products?
Signup and view all the answers
Study Notes
Regenerative Medicine
- Genes, cells, and matrix are essential components for regenerative medicine.
- Genes control cell growth and differentiation.
- Cells produce matrix molecules and enable tissue function.
- Matrix (ECM) acts as a scaffold for cells to grow and differentiate.
- Regenerative medicine mimics embryonic development by involving cell transformation and interaction with ECM.
- Combining genes, cells, and matrix is essential for developing regenerative therapies, such as engineered tissues or organ replacements.
Historical Milestones
- Gasparo Tagliacozzi (16th century) used skin grafts for reconstructive surgery.
- John Hunter (18th century) performed early experiments with tissue grafts.
- 20th century saw advancements in transplantation and the understanding of immune rejection, highlighted by the work of Sir Peter Medawar.
Extracellular Matrix (ECM)
- Provides structural support, regulates cell behavior, and influences tissue regeneration.
- Engineering stem cell niches (microenvironments where stem cells reside)
- Studying disease environments (e.g., tumor microenvironments)
- Recapitulating tissue physiology for research
Stem Cell Niches
- ECM interaction within the stem cell niche is crucial.
Tissue-Specific Niches
- Engineering ECM in diseased environments, such as tumor microenvironments.
-
Engineering and characterization of CD-ECM to study ECM physiology:
- Biological and biomechanical aspects.
Matrix Components
- Fibrous proteins: Collagen, elastin, and fibronectin.
- Growth factors: BMP (Bone Morphogenetic Proteins), Wnt signaling.
- Cell adhesion molecules: Integrins mediate interactions between cells and ECM.
Cell-Derived ECM (CD-ECM)
-
Technologies for:
- Generation
- In vitro deposition
- Decellularization and processing
Cell and Tissue Development
Embryogenesis and Primitive Streak
- Gastrulation (around 14 days after fertilization) forms the trilaminar embryonic disc.
-
Embryonic layers:
- Ectoderm: Forms the nervous system and skin.
- Mesoderm: Forms muscles, connective tissues, and the cardiovascular system.
- Endoderm: Forms the digestive and respiratory tracts.
Organ-genetic Period of Embryonic Development
- 3rd week to 5 weeks after the first day of the last normal menstrual period.
-
Four phases:
- Growth
- Morphogenesis
- Differentiation
- Maturation
Development of Specific Tissues
Skin
- Epidermis from ectoderm; dermis from mesoderm.
- Melanocytes from neural crest.
-
Development of the skin:
- Four to five weeks
- Epidermis - derived from surface ectoderm
- Dermis - derived from mesoderm
Cartilage and Bone
- Mesoderm forms cartilage, which later ossifies into bone.
-
Cartilage development:
- Five weeks
Bone
-
Development of bone:
- Paraxial mesoderm forms somites.
- Intramembranous ossification (flat bones)
- Endochondral ossification (long bones)
- Osteoblast, haversian system, osteocyte, osteoclast
Muscle Types
- Skeletal, smooth, and cardiac muscles develop from the mesoderm.
Skeletal Muscle
-
Development of skeletal muscle:
- Seven weeks
- Myotome regions of the somites (mesoderm)
- Mesenchymal cells
Smooth Muscle
-
Development of smooth muscle:
- Somatic mesoderm - vessels smooth muscle
- Mesenchymal cells - myoepithelial cells in glands
- Splanchnic mesenchyme - other smooth muscle around endoderm
- Remain mononuclear
Cardiac Muscle
-
Development of cardiac muscle:
- Four weeks
- Lateral splanchnic mesoderm
- Cardiac muscle fibers arise from single cells.
Neural Tissue
-
Development of the peripheral nervous system (PNS)
- Neural crest cells
- Cranial, spinal visceral nerves and cranial, spinal and autonomic ganglia
- Bipolar sensory cells
- Satellite cells
- Schwann cells
- Connective tissue outside the capsule
Key Molecules in Morphogenesis and Regeneration
- Morphogenesis of tissue and organ involves complex interactions, cell movement, cell transformation (EMT, MET), and programmed cell death.
Cell Transformation: EMT and MET
-
Epithelial-Mesenchymal Transition (EMT):
- Cells lose epithelial characteristics (organized and tightly connected) and gain mesenchymal properties (more mobile).
- Occurs in cancer metastasis and embryonic development.
-
Mesenchymal-Epithelial Transition (MET):
- Reversal of EMT, crucial in kidney development and tissue repair.
Bone Morphogenetic Proteins (BMPs)
- Regulate tissue development and are critical for organs like the heart and kidney.
- Functions:
- Binds to heparin sulfate, heparin, type IV Collagen.
- Regulates cell type specification, maturation, apoptosis, chemotaxis, mitosis, differentiation, and ECM production.
Cadherins
- Mediate cell-cell adhesion.
- Loss of function can disrupt tissue formation (e.g., N-Cadherin in the neural tube).
Integrins
- Act as receptors for ECM, facilitating communication between cells and their environment.
- Heterodimeric transmembrane protein αβ subunits.
- 15 subtypes of α and 8 β.
- Arginin-glycine-aspartate (RGD) sequence and the neighboring modulatory site.
Cell and Matrix Molecule Interaction; Organogenesis & Regeneration
-
Matrix proteins:
- Fibrous structural proteins: collagen, laminis, fibrinectin, vitronectin, and elastin.
- Specialized proteins: growth factors, small matricellular proteins, small integrin-binding glycoproteins (SIBLINGD).
- Proteoglycans
- Matrix degrading enzymes: MMP; serine protease; cysterine protease
-
Cells:
- Cell proliferation
- Survival
- Shape
- Migration
- Differentiation
-
Interaction:
- Growth factors: BMP/TGFβ, Wnt Signaling
- Cell adhesion molecules
- Cell-ECM interactions: Integrin and receptors;
- Cell-Cell interactions: Eph/ephrin family;
- Matrix molecules and their ligands
Key Points
- Morphogenesis of tissues and organs starts from cell and matrix molecule interactions.
- Morphogenesis is a sequential multi-step cascade.
- Tissue morphogenesis relies on cells exchanging their neighbors.
- Regeneration recapitulates embryonic development.
- Genes, cells, and matrix are essential components for engineering regenerative medicine.
Skin Reconstruction and Dermal Equivalents
- Skin serves as a waterproof barrier, sunshield, and armor.
-
Skin cells:
- Epithelial layer: Keratinocytes (90%), melanocytes (pigmentation), immune cells
- Dermal layer: fibroblasts (matrix), endothelial cells (vascular supply), hair follicle cells
Why Treat Skin Injuries?
- Skin's Importance: Acts as a waterproof barrier, sunshield, and armor.
- Self-repair but can struggle after severe burns.
-
Complications of Burns:
- Infection, scarring, and sepsis (potentially fatal).
- Goal is to reduce inflammation and cover the wound quickly to prevent complications.
- Healing time matters.
Wound Debridement
- Removal of dead tissue promotes healing.
- Traditional surgical removal is a method.
- Bromelain, an enzyme from pineapple, can be used for hard-to-reach areas.
- REIMS/i-knife differentiates between healthy and dead tissue in real-time using diathermy and mass spectrometry.
Skin Grafts
-
Split-thickness skin grafts (STSG) are commonly used.
- Limited expansion (1:3 to 1:5).
- Donor site morbidity includes pain, discolouration, scarring, and risk of infection.
- Mesh pattern of healed skin.
-
Xenografts are temporary, derived from animals (pigs, cats, rabbits, pigeons, or mice).
- Usually not cultured.
- Vigorous rejection limits them to temporary biological dressings.
-
Allografts are from human donors (cadaveric or neonatal).
- May or may not be cultured.
- Eventual rejection due to HLA-DR antigens.
- Immunosuppressive therapy is required to prevent early rejection.
- Risk of cross-contamination.
- Autologous Cells (from the patient) are the gold standard due to eliminating rejection risk.
Autologous Keratinocyte-Based Treatments
-
Cultured Epithelial Autografts (CEAs):
- Cells are grown from a full-thickness biopsy over 3-5 weeks.
- Provides good coverage but requires precise timing to reduce scarring.
-
ReCell Spray-on Skin:
- Uses cells from the dermal-epidermal junction in a spray form.
- Contains keratinocytes, fibroblasts, melanocytes, and endothelial cells.
Role of the Extracellular Matrix (ECM) and Dermal Scaffolds
- ECM's importance: Initially seen as passive support, it's now recognized for actively influencing healing through physical and biological properties.
- Types of Matrices for Burn Treatment:
- Integra: Collagen-based matrix that supports healing and is biodegradable.
- BTM: Synthetic matrix with two layers: one non-biodegradable, and the other biodegradable to integrate with tissue.
- Apligraf: Bilayered cultured graft containing both dermal and epidermal layers.
Future Innovations in Skin Regeneration
-
Stem Cells:
- Moving from skin-derived cells to multipotent stem cells (like mesenchymal or adipose-derived).
- Induced pluripotent stem cells (iPSCs) and reprogrammed cells are being explored for better regeneration.
- Improved Scaffold: Scaffold type (material, design) has a significant impact on guiding cellular responses.
-
3D Bioprinting:
- Uses bioinks (a mixture of cells and matrix) to print layers of tissues.
- Allows customization of matrix stiffness and biological activity.
- Goal: Print complete tissue structures ready for transplantation.
Understanding the regenerative cells and matrix required
- Vascularisation
- Timing – to be connected surgically to replacements? Designed within the bioengineered replacements?
- Timeline of skin repair methods
Future Development
- Single stage replacements
- Integrated cellular/matrix guided regeneration
Advanced Therapy Medicinal Products (ATMPs)
- ATMPs are therapeutic goods including cell-based products, immunotherapy products, combination products, products containing live animal cells, tissues or organs, and autologous human cells and tissue products (including stem cells).
- ATMPs are distinct from biological medicines which include recombinant products, plasma derived products, vaccines (that do not contain viable human cells), and gene-therapy vectors alone.
- ATMPs have been substantially manipulated or not intended for the same essential function in the recipient and the donor.
- ATMPs containing Genetically Modified Organisms (GMOs) are regulated by the Office of the Gene Technology Regulator (OGTR) in Australia.
- The OGTR ensures compliance with the Gene Technology Act 2000, Gene Technology Regulations 2001 and corresponding state and territory legislation.
- ATMPs require specialized and accredited cleanroom facilities for receipt, processing, manufacturing, storage and dispensing.
- Staff must demonstrate expertise in GMP, GCP, EMP, EMS, QC testing, thaw and infusion, aseptic cell processing, gene therapy formulation, and specialized equipment and materials.
ATMPs – Cell Therapies
- Hematopoietic stem cell transplant (HSCT) is a vital cell therapy for various blood cancers, such as multiple myeloma, Hodgkin and Non-Hodgkin lymphoma, acute myeloid leukemia, acute lymphocytic leukemia, myelodysplastic syndrome, myelofibrosis, essential thrombocytosis, polycythemia vera, and sickle cell disease & thalassemia.
- Cell and Tissue Therapies WA (CTTWA) at Royal Perth Hospital (RPH) is a state-of-the-art facility for receiving, storing, manufacturing, and dispensing ATMPs.
- CTTWA offers clinical services for blood cancers, serum eye drops for dry eye syndrome, and autologous gene modified cell therapies.
Autologous Gene Modified Cell Therapies
- CAR T-cell therapy is used for treating cancer patients by modifying their immune system to target and destroy cancer cells.
- Chimeric Antigen Receptor (CAR) T-cells are engineered immune cells that specifically recognize and bind to cancer cells.
- CAR T-cells are currently used for treating acute lymphoblastic leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL).
Clinical Trials
- Clinical trials for treating solid cancers, specifically melanoma, using tumor infiltrating lymphocytes are underway.
- Clinical trials for treating corneal endothelial cell loss, a leading cause of visual impairment and blindness, using injected corneal endothelial cells are ongoing.
- Clinical trials are investigating the use of mesenchymal stem cells (MSCs) for tissue regeneration, specifically cranial reconstruction.
- MSCs are multipotent stem cells found in various tissues like bone marrow, adipose tissue, umbilical cord, placenta, amniotic fluid, blood, and fetal tissue.
- MSCs have immunosuppressive and immunomodulatory properties, playing a crucial role in supporting tissue repair and controlling inflammatory reactions.
- CTTWA offers contract research and GMP manufacturing services for cell, tissue, and gene therapy products.
FACT Accreditation (Foundation for the Accreditation of Cellular Therapy)
- FACT was established to promote minimum standards and collaboration in the field of cellular therapy.
- FACT promotes quality patient care and laboratory practices, improves treatment outcomes, and fosters research and development of cellular therapies.
- Accreditation under FACT is voluntary but highly valued by BMT programs, hospital administrators, third party payers, and cooperative groups conducting clinical trials.
Tissue Engineering
- The field of tissue engineering aims to create substitutes for tissues that have been damaged or lost, aiming to restore or enhance tissue function.
- Key components of tissue engineering include cells, biomaterials/scaffolds, and growth cues.
Challenges in Tissue Engineering
- Technical challenges include developing reliable scaffolds.
- Commercial challenges involve making tissue engineering solutions cost-effective and translating them into practical therapies.
- Regulatory and ethical challenges include navigating approval processes and ethical concerns, particularly with animal or donor cells.
Native Tissues
- Native tissues rely on:
- Cells: Building blocks and maintainers of organs.
- Extracellular Matrix (ECM): Provides structural and biochemical support.
- Vessels: Supply oxygen and nutrients to keep cells alive.
Tissue Engineering Paradigm
- The approach involves the use of cells, biomaterials (scaffolds), and growth cues to mimic the structure and function of native tissues.
- Cell sources include autologous, allogeneic, and xenogeneic cells.
- Allogeneic and xenogeneic cells often lead to immune rejection.
- The choice of biomaterial influences scaffold design, which guides cell behavior, morphology, adhesion, and motility through biophysical and biochemical cues.
- Biological factors such as hormones, cytokines, growth factors, ECM molecules, cell surface molecules, and nucleic acids play a significant role in regulating cell fate.
- The physical and chemical nature of the scaffold also play a crucial role in cell fate regulation.
- Mechano-chemical factors contribute to the temporal and spatial coordination of cellular processes via signals from the ECM.
Cell-Environment Interactions
- Cells interact with their environment through various biochemical, mechano-chemical, and physical mechanisms.
- Cell-extracellular matrix (ECM) interactions are essential for cell function.
- Mechanotransduction involves the conversion of mechanical forces into biochemical signals.
- Integrins, cell adhesion receptors, play a crucial role in mechanotransduction and cell adhesion.
- Cellular processes, such as shape changes in epithelial cells and geometry of tubules, are influenced by mechanical cues.
Biomaterials in Tissue Engineering
- Scaffolds serve as templates for tissue regrowth, providing physical structure and cues for cell attachment and growth.
- Scaffolds must possess adequate mechanical properties, be biocompatible (not rejected by the body), biodegradable (degrade as natural tissue regenerates), and porous to allow for tissue regeneration and attachment.
- The fabrication process of scaffolds is crucial for precision, reproducibility, compatibility with cells and signals, tailored size and shape, and cost-efficiency.
- The mechanical properties of scaffolds are a critical factor in guiding tissue regeneration and influencing cell behavior.
Types of Scaffolds
- Bioinks: Soft hydrogels used in bioprinting, suitable for suspension of cells, drugs, and biologically active materials.
- Biomaterial Inks: Harder polymers used to create solid structures in bioprinting.
- Both bioinks and biomaterial inks contain cells.
- Hydrogels, a common bioink material, are 3D hydrophilic polymer networks that can absorb large amounts of water and possess biocompatibility and biodegradability.
Design Considerations for Bioprinting
- Bioprinting technologies offer precise control over scaffold design, enabling the creation of complex and intricate structures.
- Different bioprinting technologies include extrusion-based bioprinting, hydrogel bioprinting, and melt electrowriting (MEW), each with its own set of advantages and limitations.
- Challenges in extrusion-based bioprinting include cell sinking, cartilage changes, cell stress, needle clogging, material dehydration, and collapsing structures.
- Hydrogels are widely employed as biomaterials in bioprinting due to their resemblance to the ECM and their ability to create a true 3D environment for cells.
- Strategies to enhance shape fidelity in bioprinting often involve the use of supporting structures.
Scaffolds for Soft Tissues
- Scaffolds for soft tissues are often designed to mimic the microarchitecture and mechanical properties of the target tissue.
- Collagen, a key structural protein in the ECM, is frequently used in soft tissue scaffolds due to its biocompatibility and biodegradability.
- The use of micrometre-sized collagen bundles in 3D bioprinting aims to emulate the properties of soft tissues, promoting the formation of tissue-like structures.
3D Bioprinting
- 3D Printing, including techniques like Melt Electrowriting (MEW), allows for the creation of complex scaffolds with high resolution and precision.
- MEW offers control over the mechanical properties of printed scaffolds, making it suitable for both bone and soft tissues.
- MEW enables the fabrication of scaffolds with fine structures and precise mechanical properties.
Scaffolds for Heart Valves
- Heart valve replacement is a critical procedure for patients with aortic stenosis, congenital valve diseases, and other cardiovascular conditions.
- Current clinical solutions for valve replacement include mechanical valves, bio-prosthetic valves, and tissue-engineered heart valve solutions.
- Tissue-engineered heart valve solutions, such as those developed by Xeltis, aim to provide a more biocompatible and durable alternative to existing valve replacement options.
Optimised Biomimetic Scaffold Design
- The development of scaffolds for heart valves requires careful consideration of design factors including cell recruitment, tissue integration, biocompatibility, biodegradability, and mechanical properties.
- Spatially heterogeneous scaffolds, mimicking the complex structure of heart valves, can be achieved through bioprinting techniques like MEW.
- Bio-inspired MEW design incorporates insights from the natural structure and function of heart valve tissues to create optimized scaffolds.
Cellular Engineering in Surgical Intervention
- Milestone: Organ transplant -> Material Implant -> Cellular Engineering
- Material implants: Breast implants, total knee replacements, with limited lifespan (around 15 years) and require replacement
-
Delivery systems of cellular engineering: Stem cells, tissue progenitor cells, cell suspension
- Cell suspension: Single cells requiring homing, local or systemic impact; immunomodulatory disease; host vs graft disease. Example: CAR-T
- Cell cluster: Cell carriers with no matrix production, local effect, good integration
- Tissue construct: Immature but functional matrix, local effect, poor integration. Example: Organ-on-a-chip for drug screening
- Joint and osteochondral structure: Joint lining is made of cartilage, lacking blood supply and nerves. Defects are asymptomatic
- Cartilage tissue does not regenerate
Cartilage Injury
- Irreversible damage leading to Osteoarthritis (OA)
- 30,000 to 40,000 cartilage injuries annually in Australia, costing $30 million
- Current treatments (pharmaceuticals, arthroscopy, marrow perforation techniques, osteochondral allo/autografting) only treat symptoms or produce inferior repair tissue.
- Microfracture can cause bone cyst formation
Matrix-Induced Autologous Chondrocyte Implantation (MACI)
- Advanced technique for repairing damaged cartilage
-
Involves:
- Harvesting patient’s own chondrocytes (cartilage cells)
- Seeding the cells onto a collagen membrane scaffold
- Implanting the scaffold back into the joint to repair the damaged area.
-
Autologous chondrocyte implantation using collagen membrane as scaffold:
- Less invasive
- Non-periosteal harvesting
- Non-suturing
- Better quality control of cell density
-
MACI in Australia:
- Direct chondrocytes seeding on collagen scaffold at the time of surgery
- 70% mini-surgery, 30% arthroscopic implantation
- Used in knee, ankle, shoulder, and hip
-
How MACI works:
- Cell seeding on scaffold: Chondrocytes loaded onto collagen membrane
- Fibrin glue secures the scaffold without sutures, reducing surgery time
- Implanted cells integrate into the damaged area, creating hyaline-like cartilage
-
Advantages:
- Less invasive (no periosteum harvesting)
- Better quality control of cell density
- Can be performed arthroscopically or through mini-surgery
Clinical Outcomes of MACI
- Significant improvements in pain and joint function within 2 years, benefits lasting up to 10 years
- Post-surgery assessments show sustained recovery over time
- Long-term outcome study (N=60) in Perth, Australia
Key Technique Aspects
- Collagen membrane replaces periosteal membrane
- Direct integration of chondrocytes onto the collagen membrane through loading
- Fibrin glue replaces suturing, shortening the surgical procedure and preventing graft hypertrophy
Challenges and Innovations
- Microfracture can lead to bone cysts, avoided by MACI's cell-loaded scaffold
- Synthetic materials used in the past failed due to complications, MACI focuses on collagen-based scaffolds for better integration
Future Directions for Joint Repair
- Goal is to repair the entire osteochondral region (bone + cartilage)
- Techniques under exploration:
- Bioactive scaffolds with growth factors (TGF-β, BMPs) to enhance cell growth
- Stem cell-based therapies (concerns about unapproved stem cell treatments harming research)
Key Takeaways
- MACI is a second-generation improvement over traditional autologous chondrocyte implantation (ACI)
- Australia leads in developing and adopting MACI, 15 years ahead of the USA
- MACI is expensive and only targets cartilage repair, not full joint restoration
Regulatory Considerations
- Clinicians must define appropriate uses for stem cells to protect regenerative medicine credibility
- Regulatory frameworks are needed to ensure safe and effective therapies
Conclusions
- MACI produced improved clinical outcomes and functional hyaline-like repair tissue infill up to 10 years
- MACI is still a very expensive cell therapy technology
- MACI only repairs cartilage
- Future of joint repair is to repair the full osteochondral region with barrier or memory structures
Future Regenerative Therapies
- Osteochondrogenesis
- Chondroconduction
Recommendations
- Establish boundaries for stem cell therapy practice
- Improve community engagement and awareness of stem cell research and therapy
- Improve patient access to clinical trials
- Facilitate cross-disciplinary collaboration
- Specialist use only
- GMP manufacture / Process characterization
Liver Progenitor Cells
- Liver disease has increased significantly, activating hepatic non-parenchymal cells (Kupffer) and releasing factors like TNF and IL-6.
- Other factors are secreted from various glands, including the pancreas (insulin), duodenum, salivary gland (EGF), adrenal gland (norepinephrine), and thyroid gland (T3).
- Stellate cells release HGF, enabling hepatocytes to overcome cell cycle checkpoints.
- Transformation Growth Factor (TGF) inhibits hepatocyte DNA synthesis but is blocked during regeneration.
-
Regeneration of liver cells:
- Cholangiocytes: Derived from embryonic hepatoblasts/oval cells in mice, peaking in proliferation shortly after hepatocytes.
- Liver Sinusoidal Endothelial Cells (LESCs): Proliferation lasts for days to weeks, with precursor migration from bone marrow.
- Kupffer Cells and Immune Cells: Local Kupffer cell proliferation, migrating as mononuclear cells from the blood to become liver resident macrophages.
- Hepatic Stellate Cells (HSCs): Contribute to fibrosis and cirrhosis but also produce signaling molecules essential for regeneration.
-
Hepatic Progenitor Cells (HPC):
- Bi-potential stem cells in human and animal liver that differentiate into hepatocytes and cholangiocytes.
- Located in the canal of herring, HPCs grow as extensions of terminal biliary ductules.
- Oval cells form ductular structures connecting the biliary system and terminating at a hepatocyte-forming blind end.
- Induced by liver damage, oval cells can be isolated and cultured to produce both hepatic cells and cholangiocytes.
Liver Diseases
-
Genetic liver diseases:
- Examples include Hemophilia B, Crigler-Najjar Syndrome, Wilson Disease, and Alpha-1 Antitrypsin Deficiency (AATD).
- Treatment options often involve gene therapy using AAV vectors and CRISPR/Cas9 technology.
-
Gene therapy tools include:
- AAV vectors: Deliver corrected genes into liver cells.
- CRISPR/Cas9: edits faulty genes.
-
Induced pluripotent stem cells (iPSCs):
- Derived from adult cells and reprogrammed to an embryonic-like pluripotent state.
- Promising for ex vivo gene therapy and cell therapy applications.
-
Metabolic liver diseases:
-
Lifestyle causes include:
- Alcohol
- Obesity
- Viral infections (HCV, HBV)
- Intravenous drug use
-
Lifestyle causes include:
Regenerative Medicine and Liver Disease
- Regenerative medicine: Replacing, engineering, or regenerating human cells, tissues, or organs to restore normal function.
- Cell therapy: Introduction of cells into an organism's tissues to treat a disease.
-
Liver transplantation:
- Donor shortage and unsuitability of donated livers: Increasing demand and poor donor rates lead to limited availability for transplantation.
-
Current treatment for metabolic liver disease:
- Early stage: Liver disease resection.
- End-stage: Liver transplant.
-
Cancer (HCC):
-
Treatment options include:
- Radiofrequency/cryoablation, radiotherapy
- Partial hepatectomy
- Transplantation
- Sorafinib (5-year survival rate 17% in Australia)
- Immunotherapy (Atezolizumab, combination of Atezolizumab/Bevacizumab).
-
Treatment options include:
-
Devices:
- ALDs (Artificial Liver Device): Mechanical devices that have not proven clinically beneficial.
-
BLDs (Bio-artificial Liver Device):
- Use human liver cells to filter toxins and mimic liver function.
- Used as a bridge to transplantation for severe cases.
- Clinical trials (VTI-208) showed no significant improvement in patient outcomes.
Cell and Gene Therapy for Liver Disease
-
Hepatocyte Transplantation:
- Challenges: Immune rejection and poor donor availability.
- Animal models demonstrate: Transplanted hepatocytes can replace damaged liver tissue and restore function, correcting enzymatic, receptor, and transport defects.
- First human HTx in 1992: Unclear benefits.
-
Limitations:
- Rejection: Improved immunosuppressive regimens are needed.
- Donor availability: Good quality cells and suitable donors are required.
- Engraftment: High-grade cell engraftment is essential.
- Preconditioning: Regimens have been tried to give transplanted cells an advantage over the recipient's cells, such as partial hepatectomy.
-
Stem Cell Therapy:
-
Mesenchymal Stem Cells (MSCs):
- Used to treat fibrosis and cirrhosis by reducing liver inflammation.
- Possess immunomodulatory properties, affecting immune cell activity and HSC behavior.
-
Induced Pluripotent Stem Cells (iPSCs):
- Reprogrammed adult cells that behave like embryonic stem cells.
- Can be genetically corrected for personalized therapy.
-
Challenges:
- Incomplete gene expression.
- Scale-up issues for therapeutic use.
-
Mesenchymal Stem Cells (MSCs):
Hepatic Stellate Cells (HSCs) and Fibrosis
-
Role in Fibrosis:
- Activated during liver injury or chronic inflammation.
- Transform into myofibroblast-like cells, producing excessive collagen and extracellular matrix (ECM).
- Release pro-inflammatory cytokines (e.g., TGF-β, PDGF), promoting further fibrosis.
-
Targeting HSCs for Treatment:
- Focus on reducing their activation to prevent fibrosis progression.
Mesenchymal Stem Cells for Metabolic Liver Disease
- MSCs: Candidate stem cell types for treating liver fibrosis/cirrhosis.
- Clinical trials: 59 registered clinical trials using MSCs for liver disease, 29 focusing on liver cirrhosis (2020).
- Initial therapeutic interest: MSCs' ability to differentiate into hepatic cells.
- Accumulating evidence suggests: MSCs' therapeutic mechanisms are due to immunomodulatory effects, attenuating acute or chronic liver inflammation and hepatocyte injury through modulation of immune cell function, including HSCs.
Using Pluripotent Stem Cells to Treat Disease
- Hepatocyte-like cells: Generated from pluripotent stem cells using various growth factors such as FOXA2, HNF1a.
-
Hepatocyte characteristics:
- Cytochrome p450 enzyme activity
- LDL uptake
- Glycogen storage
- Urea synthesis
-
Limitations:
- Incomplete gene expression
- Scale-up limitations
- Heterogeneous culture
Improving Hepatocyte-like Cell Function and Cell Number
- Chemically defined conditions: Used to optimize cell culture.
- Substrates and matrix: Laminin used for embryonic stem cells and mesenchymal stem cells.
- Small molecules: Induce rapid proliferation.
- TGFb-induced proliferation and GSK3b inhibition: Promote cell growth.
- ESC/iPSC transduction: With transcription factors to promote differentiation and proliferation.
Liver Organoids and Buds
-
Organoids:
- Mini-liver structures grown from multiple cell types for transplantation.
- Use a liver-specific gel and fat-derived cells to support growth.
- Can spontaneously form small blood vessels.
-
Liver Buds:
- Resemble natural liver tissue and show potential in animal models.
- Consist of liver progenitor cells and liver endothelial cells.
-
Growing multi-cellular liver organoids for transplantation:
- Liver progenitor cells differentiate into main liver cells.
- Liver endothelial cells form blood vessels.
- A unique liver gel, fat-derived cells, and a 3mm scaffold are used to maintain organoid integrity.
Growing Liver Buds for Transplantation
-
Generating multi-cellular liver organoids from iPSCs:
- Resemble liver tissue.
- Show therapeutic potential in a mouse model.
- Clinically defined with animal-origin free media and supplements.
Summary and Future Directions
- Liver disease is a major health problem with no real solution.
- Cell therapy or a combination of cell therapy and gene therapy holds great promise.
- A range of cell types and procedures are available.
- The biological properties and outcomes of transplanting such cells need to be exhaustively defined before use in humans due to potential tumorigenicity.
- More research is needed to better understand the mechanisms of stem cell growth and development.
- Combination therapies using stem cells, gene therapy, and hepatocyte transplantation hold promise for treating liver diseases.
- Further research is required to address challenges like immune rejection, tumor risks, and incomplete cell differentiation.
- Advanced technologies like iPSCs, liver organoids, and bio-artificial devices offer new possibilities for treating severe liver conditions.
Fibrosis: A Pathological Wound Healing Response
- Fibrosis is a process where damaged tissue is replaced with excessive fibrous (scar) tissue.
- This leads to loss of normal tissue function and can occur in conditions like Idiopathic Pulmonary Fibrosis (IPF), liver fibrosis, and myocardial infarction.
Healing and Repair Processes
- Healing: Restoration of normal function, often involves scar formation.
- Regeneration: Replacement of damaged structures requiring intact tissue scaffolding and stem cells.
- Fibrosis: Excessive scar tissue formation, negatively impacting organ function.
Factors Influencing Tissue Repair
- Intrinsic cellular capacity to proliferate:
- Labile cells: Continuously divide (e.g., epithelial, bone marrow cells).
- Stable cells: Divide when necessary (e.g., liver, kidney cells).
- Permanent cells: Cannot regenerate (e.g., cardiac myocytes, neurons).
- Severity, duration, location, infection, perfusion, nutrition, and stress also influence tissue healing.
Extracellular Matrix (ECM) and Its Role
- The ECM acts as a scaffold for cell proliferation, migration, and differentiation during tissue repair.
- Controls cell behavior and acts as a reservoir for growth factors.
- Composed of polysaccharides, glycoproteins, proteoglycans, and various types of collagen.
- Fibroblasts are a major source of ECM components during tissue repair.
Wound Healing Process
- Inflammation: Removal of damaged tissue.
- Cell proliferation: New connective tissue and blood vessel formation.
- ECM synthesis: Tissue remodeling and wound contraction.
- Scar formation: Collagen deposition leads to mature scar tissue.
Fibrosis in Clinical Conditions
- Fibrosis is the excessive deposition of matrix components, replacing normal tissue with dense scar tissue, leading to functional impairment.
- Clinical examples: Liver fibrosis, post-operative adhesions, keloids, systemic sclerosis, and IPF.
Idiopathic Pulmonary Fibrosis (IPF)
- A progressive, usually fatal lung disease with a median survival of 3 years post-diagnosis.
- Characterized by abnormal tissue remodeling, collagen deposition, and loss of lung function.
- Potential causes: Dysregulated immune responses, increased TGF-β1, PDGF, and fibroblast activation.
Key Molecular Pathways
- Fibroblast proliferation and collagen production are increased in fibrosis.
- Signaling pathways like STAT3 and growth factors (e.g., IL-6, TGF-β) play crucial roles in fibrosis development.
- STAT3 signaling has been shown to increase fibrosis in pre-clinical models.
B Cells in Idiopathic Pulmonary Fibrosis
- Abnormal adaptive immune response in IPF.
- B cell aggregates are present in the lungs, similar to patients with SLE and RA.
- IPF patients have high circulating autoantibodies, increased B cells (CD19, CD20), BAFF, and immune complexes.
- Increased plasmablast and plasma cells suggest an autoimmune-like feature.
Mechanisms Driving Fibrosis Leading to New Therapeutics
- 2023 Research projects focus on understanding fibrosis in the inner ear as a complication of cochlear implant surgery and infection.
- This fibrosis can cause loss of residual hearing and function of the implant.
2023 Lung Fibrosis Research Projects
- Current therapies for IPF are limited.
- Focus on developing treatments that slow disease progression and improve quality of life.
- Research involves:
- Macromolecular crowding assay to test suitable drugs.
- Investigating differential responses of human IPF fibroblasts to drug treatment in vitro.
- B cell phenotyping and auto-antigen screening to tailor treatments for specific patient populations.
- Testing immunotherapy for lung fibrosis in mouse models.
Therapeutic Approaches
- Targeting immune cells: Research on depleting B cells and plasma cells shows potential in reducing fibrosis, particularly in IPF.
- STAT inhibitors: Small molecule inhibitors targeting STAT3 signaling are being tested for reducing fibrosis.
- Plasma cell depletion: Therapies targeting antibody-producing plasma cells (e.g., bortezomib) show promise in reducing lung fibrosis.
Immune Regulation
- Immune regulation ensures the immune system differentiates between self and non-self antigens and harmful and innocuous foreign antigens.
- T cell immunity involves killer T cells, tolerance, and activation.
- Tolerance prevents self-reactive T cells from causing autoimmunity.
- Activation generates effector T cells to fight cancer and infections.
- Dendritic cells play a crucial role in orchestrating T cell immunity.
Dendritic Cells (DCs)
- DCs are specialized antigen-presenting cells that activate T cells.
- They are categorized into three groups: circulating, lymphoid-resident, and migratory.
- DCs specialize in cross-presentation and play a vital role in presenting antigens to CD8+ T cells, crucial for anti-tumor immunity.
- It is unknown how antigens are presented to CD8+ T cells in cancer.
- Studies in melanoma highlight the involvement of Langerhans cells and dermal-derived DCs in the immune response.
Melanoma Progression
- Melanoma development progresses in stages, from epidermal confinement to spreading to lymph nodes and other organs.
- Epicutaneous inoculation models are used to study melanoma progression in mice.
Adoptive Cell Therapy
- Transfers activated CD8+ T cells to combat tumors
- Tumors are heterogeneous, making them difficult to treat uniformly.
Flt3L and Dendritic Cell Expansion
- Flt3L (Fms-like tyrosine kinase 3 ligand) expands XCR1+ dendritic cells.
- XCR1+ DCs specialize in cross-presentation and promoting CD8+ T cell responses.
- Targeting DCs through Flt3L can enhance immune responses against tumors.
Tissue-Resident Memory T Cells (TRM)
- TRM cells reside in tissues and play a critical role in controlling tumor growth.
- TRM accumulate in human cancers and are essential for long-term immune control of melanoma.
- TRM cells promote an immune equilibrium in the skin, preventing melanoma relapse.
Summary
- XCR1+ DCs specialize in cross-presentation of tumor antigens and promote CD8+ T cell responses.
- This knowledge can be utilized to develop novel therapies.
- TRM CD8+ T cells promote melanoma-immune equilibrium in the skin.
Conclusion
- XCR1+ dendritic cells and TRM CD8+ T cells are crucial for anti-tumor immunity.
- Targeting these cells could enhance immune responses against cancers.
Gene Therapy Overview
- Gene therapy aims to correct or replace faulty genes.
- It is used to treat diseases caused by mutations in specific genes, such as Duchenne Muscular Dystrophy, Severe Combined Immunodeficiency, and Sickle Cell Disease.
- The most common approach is to insert a normal copy of a gene into a nonspecific location in the genome to replace its defective counterpart.
Common Approaches to Gene Therapy
- Normal Gene Insertion: A functional copy of the gene is inserted into the genome to replace the non-functional one.
- Gene Replacement through Homologous Recombination: The faulty gene is swapped for a normal version using the natural process of recombination.
- Gene Repair: The faulty gene is corrected by inducing a selective mutation that restores its function, potentially using tools like CRISPR.
- Gene Regulation Alteration: Gene expression can be adjusted to manage the disease by regulating the extent to which a gene is turned on or off.
How Gene Therapy Works
- A normal gene is inserted into the target cell using a vector (e.g., a virus).
-
Example: Correction of X-SCID in bone marrow cells.
- Bone marrow cells are isolated.
- Cells are transfected in vitro with a retrovirus carrying the "normal" version of the X-SCID gene.
- The retrovirally-transfected genes are tested for integration and expression.
- The transformed bone marrow cells are returned to the patient.
Viral Vectors in Gene Therapy
- Viruses are effective at inserting their genetic material into host cells, making them suitable for gene therapy.
- Adenoviruses: Double-stranded DNA viruses that cause respiratory, intestinal, and eye infections. They can carry large genes but do not integrate permanently into the host's genome, making their effects temporary.
- Adeno-associated Viruses (AAVs): Small, single-stranded DNA viruses that can insert their genetic material at a specific location on chromosome 19. They can integrate into the host's genome, providing stable gene expression and are often used for long-term gene therapy.
- Herpes Simplex Viruses: Double-stranded DNA viruses that infect neurons. They can remain in the body for long periods, making them ideal for gene therapy targeting nervous system diseases.
- Retroviruses: Convert their RNA genome into DNA, which can then integrate into the host cell’s genome permanently. An example is HIV.
-
Example:
-
X-SCID correction:
- Bone marrow cells are isolated from a patient.
- They are transfected in vitro with a recombinant retrovirus carrying a "normal" version of the X-SCID gene.
- The retrovirally transfected genes are tested for integration and expression.
- The transformed bone marrow cells are returned to the patient.
-
X-SCID correction:
Non-Viral Gene Delivery Systems
- Less efficient but offer an alternative to viral vectors.
- Direct Injection: Injecting DNA directly into tissues, but with a low efficiency of DNA uptake by cells.
- Electroporation: Using an electrical current to make cell membranes more permeable, increasing the efficiency of DNA uptake.
- Gene Gun: Shoots DNA-coated particles into cells, mainly used in plant research.
- Liposomal Delivery: DNA is packaged in fat bubbles that fuse with cell membranes, allowing DNA to enter cells.
Duchenne Muscular Dystrophy (DMD)
- A severe, muscle-wasting disease caused by mutations in the dystrophin gene.
- Primarily affects boys as it is an X-linked recessive disorder.
- Patients are typically wheelchair-bound by age 12 and die in their 20s or 30s due to cardiac or respiratory failure.
- The dystrophin gene produces a protein responsible for muscle stability and function.
- Mutations in the dystrophin gene can be nonsense, frameshift, or in-frame.
Therapeutic Approaches for DMD
- Mini Dystrophin Gene Delivery: Uses shortened versions of the dystrophin gene, inspired by Becker Muscular Dystrophy, which are small enough for viral delivery and retain functionality.
- Transcriptional Read-Through: Some antibiotics, like gentamicin, can help cells read through premature stop codons in the dystrophin gene, potentially restoring protein production.
- Exon Skipping: Uses modified RNA molecules to skip over defective exons, allowing the production of a shorter but functional dystrophin protein. This approach has shown promise and is in clinical trials.
- Homologue Induction: Increases the expression of utrophin, a protein similar to dystrophin present in embryonic muscles, to compensate for the lack of dystrophin.
- Myoblast Transfer Therapy (MTT): Transplants myoblasts, muscle precursor cells, from healthy donors into DMD patients. The goal is to have these cells fuse with the patient's muscle cells and provide functional dystrophin.
Challenges in Gene Therapy for DMD
- Immune Response Issues: The immune system often rejects myoblasts transplanted in myoblast transfer therapy.
- Regulatory T Cells (Tregs): Immune cells that help regulate the immune response and could potentially reduce myoblast rejection. Researchers are investigating ways to boost the number of Tregs in muscle tissue to protect donor myoblasts.
- Cytokine Therapy: Experimented with to enhance Treg activity and suppress the immune response.
Key Takeaways
- Gene therapy is a rapidly evolving field with potential for treating genetic diseases, but challenges remain.
- Viral vectors are common but non-viral methods are gaining traction due to safety concerns.
- New approaches offer hope for treating DMD, including exon skipping and cytokine-enhanced myoblast transfer.
- Success requires the right delivery system, addressing immune system challenges, and ensuring long-term gene expression.
What is Gene Therapy?
- Gene therapy aims to treat or prevent disease by inserting genes into a patient's cells.
- It offers an alternative to traditional drug or surgical treatments.
- Gene therapy applications include:
- Replacing faulty genes with healthy copies.
- Deactivating mutant genes.
- Introducing new genes to treat complex diseases or generate essential proteins.
Viral Vectors in Gene Therapy
- Modified viruses, known as vectors, deliver genes into cells.
- These vectors are engineered to infect cells but lack disease-causing genes.
- Viruses are chosen as vectors due to their ability to efficiently enter cells.
- Common viral vectors include Adeno-Associated Virus (AAV), Lentivirus, and Retrovirus.
Ocular Gene Therapy
- The eye is a suitable target for gene therapy due to several factors:
- It is a small, compartmentalized organ, requiring smaller treatment doses.
- The eye enjoys immune privilege, reducing the risk of rejection.
- Contralateral control allows for comparison between treated and untreated eyes.
- Its accessibility enables easy monitoring of gene therapy effects.
- Certain AAV serotypes demonstrate effectiveness in eye delivery.
Developing a Gene Therapy Strategy
- Key steps in developing an ocular gene therapy include:
- Understanding the biology of the targeted disorder.
- Selecting the appropriate gene and vector for delivery.
- Testing the therapy in biological models (animal models or human-derived retinal cells).
- Ensuring safety through animal trials before human trials.
- Conducting clinical trials to assess therapeutic efficacy.
Types of Gene Delivery in the Eye
-
Subretinal Injection:
- Involves injecting the gene therapy directly beneath the retina, targeting photoreceptor cells.
- Highly specific but requires delicate surgery.
- Essential for diseases affecting light-sensing cells, such as Leber Congenital Amaurosis (LCA).
- Creates a local bleb (detached retinal area) that reattaches after injection.
- Risk of tissue loss if the bleb does not reattach.
-
Intravitreal Injection:
- A less invasive procedure where the vector is injected into the vitreous cavity.
- Easier to perform and often used for treating ganglion cells (e.g., in glaucoma).
- Less effective targeting for outer nuclear layer (ONL) cells, including photoreceptors.
- Generates a stronger immune response due to widespread distribution.
-
AAV Properties:
- Small (25 nm) with a single-stranded DNA genome (~5 kb).
- Non-pathogenic.
- Replication-deficient, requiring a helper virus like adenovirus.
- Effective in both dividing and non-dividing cells.
- Exhibits high-level, stable expression and low immunogenicity.
- Limited genome packaging capacity restricts the size of therapeutic genes that can be delivered.
AAV Tropism in the Retina
- Different AAV serotypes vary in their ability to target specific retinal cells.
- AAV2, AAV8, and AAV9 are effective in the retina, but some are better suited for specific retinal layers.
- Subretinal delivery typically targets photoreceptors, while intravitreal injections are better for ganglion cells.
Gene Therapy Examples: Bench to Bedside Pipeline
-
Leber Congenital Amaurosis (LCA):
- Inherited eye disease caused by RPE65 gene mutations.
- Symptoms appear at birth or in early childhood, leading to severe visual impairment or blindness.
- The first FDA-approved gene therapy for LCA.
- Involves replacing the defective RPE65 gene with a healthy copy via AAV-mediated delivery.
- Animal studies (dogs and mice) showed remarkable improvement in visual function.
- Over 11 clinical trials resulted in FDA approval in 2017.
- Treatment demonstrated long-term vision restoration and improved retinal function.
-
Age-Related Macular Degeneration (AMD):
- A progressive vision loss condition caused by abnormal blood vessel growth in the retina (wet AMD).
- High levels of vascular endothelial growth factor (VEGF) contribute to the disease.
- Current treatments involve frequent anti-VEGF injections to block VEGF activity.
- Gene therapy solution: AAV vectors deliver genes encoding soluble VEGF receptor 1 (sFlt-1), inhibiting VEGF activity.
-
Preclinical studies:
- Tested in the Kimba mouse model of chronic retinal degeneration.
- Non-human primate studies showed safety, long-term efficacy, and lack of toxicity.
-
Clinical trials:
- A trial at the Lions Eye Institute demonstrated promising results, with fewer injections and maintained visual acuity.
Challenges in Gene Therapy
- Limited genome capacity: AAV can only carry small genes (~4.7 kb), limiting the deliverable gene size.
- Pre-existing immunity: Many individuals have anti-AAV antibodies from previous infections, neutralizing the viral vector.
- Delivery method: The choice of delivery method (subretinal vs. intravitreal) impacts the therapy's effectiveness.
Current and Future Trials
- AAV-based gene therapies are being tested for various ocular conditions.
- Trials for wet AMD are ongoing, using different AAV serotypes and injection methods.
- New therapies are being explored for complex conditions like diabetic retinopathy and glaucoma.
Introduction to Molecular Therapies
- Molecular therapies manipulate gene expression to treat rare inherited disorders.
- This involves altering transcription, splicing, and translation processes.
- Over 10,000 single-gene disorders are identified, but only 600 have available treatments.
- All genetic mutations implicated in diseases present targets for molecular intervention.
Gene Expression Overview
- Humans have approximately 42,000 genes, half of which are protein-coding.
- Many genes undergo alternative splicing, resulting in over 30 million transcripts and complex protein products.
- Alternative splicing is crucial in determining gene expression patterns.
- Splicing can produce diverse protein isoforms with varying functions.
- Disruptions in splicing can cause various diseases, making splicing an important therapeutic target.
Mechanisms of Genetic Mutations
-
Types of Mutations:
- Missense Mutation: Alters protein structure, leading to loss or gain of function.
- Nonsense Mutation: Introduces a premature stop codon, resulting in truncated and non-functional proteins.
- Repeat Expansion: Seen in diseases like Huntington’s, with increased repeats leading to earlier onset and more severe symptoms with each generation.
- Genetic modifications and diseases are influenced by factors such as non-coding RNAs, trans-acting factors, and epigenetics.
Therapeutic Approaches
- Gene Replacement: Gene therapy replaces faulty genes entirely, while molecular therapies target gene expression at various stages (e.g., splicing, transcription).
- Antisense Oligonucleotides (AOs): Synthetic molecules modulate mRNA splicing, block translation, or induce RNA degradation, providing precise treatment options for genetic diseases.
Challenges in Rare Diseases
- Rare Diseases Stats: Over 6,000 rare diseases affect 300 million people worldwide, with a high fatality rate and 95% lacking treatment.
- Diagnosis often takes years, and many conditions remain unexplained.
- They collectively affect more people than cancer.
- The changing demographics due to migration make rare diseases a global concern.
Opportunities for Intervention
- Molecular therapies offer potential for treating diverse genetic disorders through various mechanisms.
- The text highlights specific examples, including:
- Duchenne Muscular Dystrophy (DMD):
- Caused by mutations in the dystrophin gene, leading to progressive muscle degeneration.
- Antisense oligonucleotide therapies are being studied to skip exons and restore a functional reading frame, potentially reducing disease severity.
- Spinal Muscular Atrophy (SMA):
- Caused by deletion of the SMN1 gene, resulting in motor neuron death.
- Antisense therapies like "Nusinersen" promote exon expression and improve survival rates in affected infants.
- Retinitis Pigmentosa:
- Antisense therapies are being investigated to downregulate harmful transcripts and preserve vision in this degenerative eye disease.
- Duchenne Muscular Dystrophy (DMD):
DMD
- DMD is a fatal X-linked muscular wasting disorder affecting 1 in 3,500 boys.
- Frame-shifting or nonsense mutations in the dystrophin gene cause the disease.
- Progressive disease leads to eventual respiratory or cardiac failure.
- Protein truncation due to mutations leads to a severe phenotype.
- BMD (Becker Muscular Dystrophy) is a milder allelic disorder with in-frame deletions that result in dystrophin levels greater than 3% of normal.
- BMD phenotypes can be variable, with large deletions sometimes associated with mild or asymptomatic disease.
Muscle Damage in DMD
- Dystrophin acts as a mesh around muscle fibers.
- Lack of dystrophin weakens muscles, leading to muscle fiber tears and contraction-induced damage.
- Damaged tissue attracts calcium, making the membrane leaky and allowing creatine kinase to leak out.
- Elevated creatine kinase levels in the blood indicate muscle damage.
- Proteases digest muscle fibers, leaving behind satellite cells (muscle stem cells) which proliferate under growth factor influence (like IGF) and fuse to form new muscle fibers.
- The repair process is limited, and muscle regeneration often fails, leading to scar tissue formation.
- Antisense oligonucleotide therapies target specific exon 50-51 to block splice sites and restore a functional reading frame.
- Clinical studies from 2008 to 2016 involved morpholino nucleic acid analogues like AVI 4658, eteplisen, and Exondys51.
Exondys51
- Ten years of preclinical studies using treatment of neonatal mdx (dystrophic) mice showed the ability to prevent the onset of dystrophy.
- Exondys51 was approved by the FDA on September 19, 2016.
Spinal Muscular Atrophy (SMA)
- Caused by homozygous deletion of the SMN1 gene.
- SMN provides survival signals to motor neurons.
- Ongoing motor neuron death leads to respiratory failure between 6-13 months of age.
- It is the second most common genetic cause of death.
- The most severe form (Type I) affects 1 in 10,000 births.
- Less severe forms (Type II and III) affect 1 in 24,000.
AAVmdys
- Gene therapy producing tiny dystrophins.
CRISPR-Cas9 System
- CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats
- It is a naturally occurring genome editing system found in bacteria
- Bacteria capture snippets of DNA from invading viruses to “remember” them
- CRISPR-Cas9 system utilizes this mechanism to cut DNA and disable the virus
- Cas9 is the protein that cleaves DNA
- Guide RNA (gRNA) directs Cas9 to the specific target DNA sequence
- gRNA combines crRNA and tracrRNA
- crRNA (CRISPR RNA) is specific to the target DNA sequence
- tracrRNA (trans-activating crRNA) acts as a scaffold for Cas9
- PAM (Protospacer Adjacent Motif) sequence is required for Cas9 to distinguish non-self from self DNA
- Non-Homologous End Joining (NHEJ): Error-prone repair mechanism leading to insertions/deletions (indels)
- Homology Directed Repair (HDR): Precise repair mechanism that uses a template and occurs only in dividing cells
CRISPR Delivery Methods
- CRISPR components can be delivered through various methods:
- Plasmids: Long-lived but higher risk of off-target effects
- Ribonucleoprotein Complexes (RNPs): Preferable for clinical applications, rapid turnover
- mRNA: Cas9 delivered as mRNA that translates into protein
- Nanoparticles: Can improve delivery efficiency, specificity, and reduce immune cell recognition
CRISPR Applications
-
Gene Editing:
- Knockout: Disabling a gene to study its function
- Knock-in: Introducing a specific gene or mutation
- Base Editing: Precisely altering a single nucleotide using base editors
-
Gene Activation/Repression:
- dCas9 (dead Cas9): Catalytically inactivated Cas9 fused to effectors to activate or repress target loci
Clinical Applications
-
Monogenic Diseases:
- Cystic fibrosis
- Haemophilia
- Sickle cell disease
- Duchenne muscular dystrophy (DMD)
-
Other Diseases:
- Cancer
- Heart disease
- HIV infection
Case Study: Cystic Fibrosis
- Autosomal recessive disease caused by mutations in the CFTR gene
- Build-up of mucus in lungs and other organs
- Most common mutation is a deletion of phenylalanine (ΔF508)
- CRISPR can correct mutations in the CFTR gene
Challenges
- Delivery to Cells: Viral vectors have size limitations
- Ethical Considerations: Off-target effects, germline editing, regulatory issues
- Therapeutic Potential: CRISPR is highly promising for monogenic diseases but faces difficulties targeting non-dividing cells and maintaining long-term corrections.
iPSCs and CRISPR
- iPSCs (induced Pluripotent Stem Cells): High self-renewal rate and can differentiate into various cell types
- Ex vivo therapy: Correcting patient-derived cells through gene editing and transplanting them back
- Disease Modeling and Drug Testing: iPSCs can be used to model human diseases and test drugs in a patient-specific context.
Challenges in Gene Therapy
- Most common human illnesses are caused by multiple gene mutations, making targeted gene therapy difficult.
- Gene therapy in non-stem cells often results in short-lived corrections due to cell turnover.
- The body's immune system can mount a reaction against gene therapy, especially with repeated treatments.
- Gene editing tools can potentially cause unintended mutations, leading to genomic instability.
- Delivering genes efficiently into non-dividing somatic cells is a challenge.
Vector Types
- Adenoviruses are non-integrating, meaning they don't insert their genetic information into the host's genome, resulting in temporary gene expression. They often provoke immune responses.
- Adeno-associated viruses (AAVs) are generally safe and efficient for gene delivery, but have limited capacity for larger genetic sequences.
What is CRISPR?
- A bacterial defense mechanism against viruses.
- Consists of short repeated sequences with unique spacer sequences in between.
- Spacers are derived from viral or plasmid DNA.
- Relies on CRISPR-associated (Cas) genes.
- Functions as a natural immune surveillance system in bacteria.
CRISPR-Cas9 System
- Adapted from the naturally occurring genome editing system in bacteria.
- Allows bacteria to "remember" viruses by storing snippets of viral DNA in its genome.
- Uses the Cas9 enzyme to cut and disable invading viral DNA.
- Requires a Protospacer Adjacent Motif (PAM) sequence for efficient cutting, which distinguishes non-self from self DNA.
Components of CRISPR-Cas9
- Cas9 enzyme (or other Cas proteins in different bacteria).
- Guide RNA (gRNA):
- crRNA (CRISPR RNA): Sequence-specific, binds to target DNA.
- tracrRNA (trans-activating crRNA): Scaffold for Cas9 binding.
- Components can be delivered with plasmids (long-lived) or as ribonucleoprotein (RNP) complexes (rapid turnover).
- RNP delivery is preferred for clinical application due to reduced off-target effects.
CRISPR Mechanism
- Cas9 enzyme cuts DNA at specific sites guided by the gRNA.
- PAM sequence is crucial for Cas9 to induce DNA cleavage, typically 3-5 nucleotides long.
- The guide RNA (gRNA) directs the Cas9 enzyme to the target site.
CRISPR for Genomic Manipulation
- CRISPR induces DNA cleavage, initiating repair pathways:
- Non-Homologous End Joining (NHEJ): Error-prone, often used to knock out genes.
- Homology Directed Repair (HDR): Allows precise gene editing using a template, but limited to certain cell cycle phases.
CRISPR Delivery Methods
- Viral Vectors: Adeno-associated virus (AAV)
- Physical Methods: Microinjection, electroporation.
- Nanoparticle-based delivery: Lipid particles, nanoparticles.
- The choice of delivery method affects uptake efficiency and editing success.
- In vivo editing is generally more challenging than in vitro editing.
CRISPR for Gene Activation or Repression
- Catalytically inactive Cas9 (dCas9): No DNA cleavage activity but can be fused to effectors to activate or repress gene expression.
- dCas9 binding to the target site is mediated by the gRNA.
CRISPR Applications
- Research: Investigate gene function, model disease-causing mutations, create knock-ins.
- Therapeutic: Correct underlying mutations, delete mutant genes, upregulate alternative gene isoforms.
- CRISPR therapy holds potential for a permanent cure, eliminating the need for continuous drug dosing.
CRISPR Therapy and iPSCs
- iPSCs are induced pluripotent stem cells that can be differentiated into several cell types.
- Ex vivo therapy: Patient cells are corrected using gene editing and transplanted back into the patient.
- iPSCs enable disease modelling and testing in a patient-specific context.
CRISPR Therapeutic Strategies
- Allele-specific deletion of disease-causing genes using common single-nucleotide polymorphisms (SNPs).
- Upregulation of alternative gene isoforms.
Promising Therapeutic Applications
- Monogenic diseases: Cystic fibrosis, Hemophilia, Sickle cell disease, Duchenne muscular dystrophy.
- Potential applications in common diseases: Cancer, heart disease, HIV infection.
Case Studies
-
Cystic fibrosis:
- Challenges: Delivery into basal airway cells.
- Research focuses on targeting basal cells for sustainable long-term restoration of airway function.
- Base editing of stem cells from CF patients shows promise.
-
Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT):
- Mutations in the HBB gene leading to ineffective red blood cell development.
- CRISPR targeting strategies to increase levels of fetal hemoglobin (HbF).
- Clinical trials have shown successful editing in hematopoietic stem and progenitor cells, leading to transfusion independence.
-
Casgevy:
- First clinically approved CRISPR-based therapy for transfusion-dependent beta-thalassemia (TDT).
- Significant reduction or elimination of transfusion dependency, improving quality of life.
-
Duchenne Muscular Dystrophy (DMD):
- Mutations in the dystrophin gene leading to muscle degeneration.
- CRISPR is used to “reframe” the mutated gene by removing or adding specific exons, producing a functional dystrophin protein.
-
Hemophilia B:
- Mutations in the coagulation factor IX (FIX) gene causing bleeding disorders.
- CRISPR-mediated gene knock-in of FIX cDNA at the ROSA26 locus in mice achieved long-term correction of bleeding phenotypes.
-
HIV-1/AIDS:
- CRISPR editing of CCR5 co-receptor to prevent HIV-1 infection.
- Clinical trials have shown that CRISPR-edited HSCs can resist HIV-1 infection.
Clinical Trials
- 4 phases of clinical trials to ensure safety and efficacy.
- Focus on different aspects of the treatment during each phase.
CRISPR Limitations
- Delivery method: Challenges in in vivo delivery, especially with AAV vectors.
- Editing efficiency: Varies depending on cell type and tissue.
- Off-target effects: Unintended consequences that can be difficult to predict.
- Immune response: Potential for immune reactions against Cas9, gRNA, or viral vectors.
- Time and cost: Significantly high development costs and expensive treatments.
Ethical Concerns
- Eugenics: Potential misapplication for genetic manipulation.
- Misapplication: potential misuse for unethical purposes.
- Inequitable access: Concerns about unequal access to gene-editing technologies.
- Regulation: Need for strict regulations to ensure responsible use.
- Embryo modification: Ethical concerns surrounding gene editing in embryos.
Transplantation
- Solid organ and haematopoietic stem cell transplantation are common medical procedures.
- The immune system can recognize and reject transplanted tissues.
- Allorecognition is mediated by T cells and antibodies.
- Transplantation can be autologous, isologous, homologous, or heterologous.
Major Organs and Tissues Transplanted
-
Solid Organs:
- Thoracic: Heart, Lung
- Abdominal: Kidney, Liver, Pancreas, Intestine, Stomach, Uterus.
-
Cells, Tissues, and Fluids:
- Bone marrow, Stem cells, Blood transfusion, Blood vessels, Heart valve, Cornea, Limb, Skin, Islets of Langerhans, Bone.
Allograft Rejection
- Allograft rejection is a complex process involving the immune system.
- The HLA Complex on chromosome 6 plays a crucial role in allograft rejection.
- HLA class I and class II genes are involved in tissue compatibility.
- Class I HLA: Expressed on all nucleated cells.
- Class II HLA: Expressed on antigen-presenting cells (APCs), B cells, and activated T lymphocytes.
HLA Diversity and Matching
- HLA alleles are highly polymorphic, contributing to individual differences.
- HLA matching is crucial for successful transplantation.
- The MHC presents pathogen-derived peptides to T cells, initiating an immune response.
- Mismatched HLA molecules can trigger an immune response leading to allograft rejection.
Allograft Rejection and Immune Response
- Allograft rejection shares features with a normal immune response to pathogens.
- Evidence of immunologically mediated rejection:
- Latent period
- Memory (second-set rejection)
- Specificity
- Passive transfer by lymphocytes
- Production of antibodies
Immune Destruction of Kidney Grafts
- ABO blood group compatibility is essential for kidney transplantation.
- Preformed ABO isohaemagglutinins can bind to vascular endothelium causing hyperacute rejection.
- Hyperacute rejection is antibody-mediated.
Chronic Rejection
- Chronic rejection occurs months to years after transplantation.
- Gradual narrowing of vascular arterial lumen due to endothelial cell proliferation and fibrosis.
- Leads to graft ischemia, interstitial fibrosis, and tubular atrophy.
- Mechanisms include chronic endothelial damage, ongoing cellular and vascular rejection, and immune complex deposition.
HLA Matching and Renal Transplantation
- HLA matching is essential for successful kidney transplantation.
- HLA-A, -B, and -DR matching is considered in the Australian National Organ Matching Program (OrganMatch).
- Most transplants involve multiple HLA mismatches due to limited donor pool and diverse ethnic backgrounds.
- HLA mismatching is associated with increased immunoreactivity, leading to higher rates of rejection.
HLA Mismatching and Transplant Outcomes
- HLA mismatching predicts a higher frequency and potency of rejection treatment, increased serum creatinine, higher immunosuppressive drug dosage, increased risk of infection, and higher incidence of non-Hodgkin lymphoma.
- HLA mismatching can also lead to sensitization of the recipient.
- Proper HLA matching significantly influences graft survival and overall transplant outcome.
Liver Transplant
- Liver transplant is a complex procedure involving a donor and a recipient.
- Not all organs are suitable for donation, with 50-75% of organs being unusable.
- 25% of Australians donate organs.
- A donor cannot donate to a recipient, and a recipient cannot receive from their own donor.
- A patient is declared dead before organ retrieval, either by brain death (DBD) or circulatory death (DCD).
- DCD patients require therapy withdrawal, leading to a drop in blood pressure (systolic pressure below 50).
- A 5-minute waiting period is required after the heart stops beating before organ retrieval.
- The donor is then transferred to the operating room.
- Once the abdomen is opened, a catheter is inserted and the organ is perfused with the recipient’s blood.
- The organ then undergoes warm ischemic time (WIT), which is undesirable, and then cold ischemic time (CIT), which is preferred.
- WIT is the time between the cessation of blood flow to the organ and the start of perfusion.
- CIT is the time between the start of perfusion and the transplant.
- Perfect CIT is 6-9 hours within the state and 9 hours interstate, but up to 14 hours with safe outcomes.
- Livers have a short WIT limit (30-60 minutes).
- This is why cardiac donors are not preferred for liver transplants.
- Kidneys are more tolerant of WIT, with a maximum of 90 minutes.
- The quality of the liver is assessed using a scoring system based on age and the presence of fatty tissue.
- Livers with a fatty liver percentage greater than 70% are usually not used.
- Livers with a 20-40% fatty liver percentage may be acceptable, especially in younger recipients.
- The anatomy of the surrounding structures is also assessed, including accessory vessels for reconstruction.
- Variations in the anatomical structure of the liver, such as an accessory hepatic artery, are common.
- The bile duct is assessed for any damage or complications, as it is particularly sensitive to WIT.
- The most common reasons for organ donation are aneurysm and stroke.
- The organ is prepared for transport by perfusion with UW solution, which is a cold preservation solution.
- The UW solution reduces cell metabolism and maintains cell membrane stability.
- The donor’s chest is opened and the heart and lungs are perfused with the recipient’s blood.
- This perfusion is performed at the same time for all organs, marking the start of CIT.
- The organ is perfused through the abdominal aorta, which has several branches:
- Celiac artery: supplies blood to the liver, stomach, and spleen.
- Superior mesenteric artery (SMA): supplies blood to the small and large intestines.
- Inferior mesenteric artery (IMA): supplies blood to the left side of the colon.
- Left and right renal arteries: supply blood to the kidneys.
- The perfusion continues until the liquid in the artery becomes transparent with the UW solution.
- Topical and central cooling are essential for bringing the organ into CIT.
- The liver is then packed in iced water and placed within three bags of UW solution for transport.
- The donor’s kidneys can be retrieved either individually or combined for transplantation into a single recipient, depending on the size of the kidneys.
- Each organ is transported in a different colored bag.
- The surgeon carefully examines the donor organ to identify any anatomical variations or abnormalities.
- The liver is then re-constructed with five key structures, including the portal vein and the hepatic artery.
- The recipient’s liver is removed and the new liver is inserted.
- The surgical procedure is complex and requires careful reconstruction of the five main structures.
- New clinical techniques are being used to test the function of the liver before retrieval.
- Perfusion on the table is used to assess the organ’s viability and improve its overall quality.
- The recipient’s blood supply is restored to the new liver, followed by anastomosis (connection) of the bile duct.
- If the liver is too large, a device can be used to push the recipient’s ribcage up.
- Different techniques are used to address variations in the inferior vena cava (IVC), including caval replacement and cavaplasty.
- Common complications include portal vein thrombosis, which may require clot removal or bypass surgery.
- Reconstructions may involve a conduit to bypass a blocked or compromised hepatic artery.
- The Roux-en-Y procedure is used to reconstruct the bile duct if it is unusable or incompatible.
- A single donor can provide organs for two recipients.
- The entire process requires careful observation of the anatomy and meticulous surgical techniques.
Organ and Tissue Donation: Ethics and Logistics
- DonateLife: A national program in Australia that enables individuals to choose to become organ and tissue donors at the time of death.
- Legal Framework: The Human Tissue and Transplant Act 1982 and Coroners Act 1996 provide the legal foundation for organ and tissue donation.
- Rarity of Donation: Organ and tissue donation remains scarce, while the demand for transplantation continues to increase.
-
Deceased Organ Donation:
- Criteria: Donation can be considered following neurological death or circulatory death.
-
Neurological Death: Occurs after irreversible cessation of all brain function.
-
Causes:
- Traumatic Brain Injury: Road traffic accidents, gun shot wounds, falls.
- Spontaneous Intracranial Haemorrhage: Subarachnoid or intracerebral haemorrhage.
- Hypoxic Injuries: Cardiac arrest, drowning, hanging, asthma.
- Determination: Two medical practitioners, one a specialist in neurology, neurosurgery, or general medicine, must certify death.
- Clinical Testing: Includes assessment of pupil reactivity, motor function, and respiratory effort.
-
Radiological Imaging:
- Four-vessel Angiography: Visualizes cerebral blood flow.
- Radionuclide Scan: Measures brain perfusion.
-
Causes:
-
Donation After Circulatory Death (DCDD):
- Organs and tissues are retrieved after cessation of circulation.
- Decision to withdraw life support is made independently of donation decisions.
-
Pathways to Donation:
-
Neurological Death:
- Catastrophic neurological injury leads to declared death.
- Consent is obtained, and donor information collected, including tissue typing and serology.
- Organs are offered and allocated to potential recipients.
-
Circulatory Death:
- Catastrophic irreversible injury occurs.
- End-of-life care, withdrawal of treatment, and consent are managed.
- Donor information is collected, and organs are offered and allocated.
- Circulatory death is declared within 90 minutes of withdrawal, with time criteria varying based on organ allocation.
-
Neurological Death:
-
Organ Suitability:
- Organ information is provided to transplant units.
- Potential recipients are identified and tissue typing is performed for crossmatching.
-
Organ Offers: Prioritized based on:
- Urgent Listings: Patients facing immediate life-threatening situations.
-
Regional Allocations:
- Within WA: Based on recipient's location.
- Interstate: Offers considered if no suitable recipients within WA.
- Matching: Includes blood type, size match, and recipient's clinical urgency.
-
Logistics of Donation:
- Consent: Essential from the donor (AODR, No Known Objection), next of kin (if available), and potentially the Coroner.
- Family Donor Conversations (FDC): Clinicians undergo specialized training to support families in making informed decisions about donation.
-
Donor Information Collection:
- Comprehensive medical history, physical assessments, and laboratory tests are performed.
- Bloods for serology, tissue typing, and nucleic acid testing (NAT) are collected.
-
Donor Management:
- The ICU team manages organ perfusion and ensures vital signs stability.
- Proactive management includes addressing potential complications like hypotension, hypothermia, and electrolyte imbalances.
-
Ethical Dilemmas in Organ Donation:
- Balancing Patient's Rights: Ensuring patient autonomy and informed consent while respecting the potential benefits of donation.
- Minimizing Risk: Ensuring the safety and well-being of both the donor and the recipient.
- Fair Access: Ensuring equitable distribution of organs to those in greatest need.
-
Ethical Perspectives:
- Utilitarianism: Emphasizes maximizing overall wellbeing and minimizing harm, which can support organ donation as it benefits both the recipient and society.
- Deontology: Focuses on moral duties and principles, and may argue that respecting the autonomy and bodily integrity of the deceased is paramount.
-
Cultural and Religious Considerations:
- It is crucial to be sensitive to cultural and religious beliefs when discussing donation with families.
- Some religions may permit or prohibit donation, and family preferences should be respected.
-
Future Considerations:
- Increasing the organ donation rate through education, awareness campaigns, and streamlined donation processes.
- Exploring novel approaches to organ preservation and allocation.
- Expanding the use of DCDD, with consideration for patient factors and ethical considerations.
Musculoskeletal Tissue Banking
-
Bone Composition:
- 60% inorganic (calcium and phosphorus)
- 10% water
- 30% organic (collagen type I and non-collagenous proteins)
Osteogenesis
-
Bone formation and resorption:
- Occurs through a process called remodelling
- Regulated by osteoblasts (formation) and osteoclasts (resorption)
- Imbalances can lead to conditions like osteoporosis (excess resorption) or osteopetrosis (excess formation)
-
Factors involved:
- Growth factors: promote cell growth and differentiation
- Cytokines: influence bone cell function, including bone morphogenetic proteins (BMPs)
-
Functions:
- Regulate and differentiate bone cells
- Provide support for cell adhesion
- Contribute to bone matrix mineralization
Ideal Bone Substitute Properties
- Osteoconductive: Ability to serve as a scaffold for bone growth
- Osteoinduction: Ability to stimulate bone formation
- Active: Contains growth factors to promote bone formation
- Passive: Provides a supportive environment for bone growth without growth factors
- Osteointegration: Ability of the implant to integrate with the recipient's bone
- Non-immunogenic: Minimizes immune rejection
- Resorption rate/degradability: Determines how long the implant lasts
- Availability: Supply meets demand
- Easy to use: Simple to handle and implant
- Affordable: Cost-effective for patients
- Fit for purpose: Meets specific clinical requirements
- Structural integrity: Maintains shape and strength
- Biologically safe: Donors undergo rigorous screening to prevent disease transmission
- High surface area: Enhances osteoconduction
- Low risk of disease transmission: Crucial for donor screening and processing
Three O’s for Bone Growth
- Osteogenesis: Normal bone growth requiring osteoblasts and osteoprogenitor cells
-
Osteoconduction:
- Stimulation of undifferentiated cells into osteoprogenitor cells
- Induces osteogenesis
- Growth of bone through a scaffold
-
Osteoinduction (active/passive):
- Surface contact to conduct ‘growth’
- Can be achieved through growth factors (BMPs) in the case of active osteoinduction or by other environmental factors
- Facilitates communication and promotion of bone growth.
-
Osteointegration:
- Implant to recipient bone contact
- Anchors the graft
- Creates a bone-conducive environment for growth
- Material properties (biocompatibility, degradation) play a crucial role
Bone Graft Types
-
Autograft:
- Patient's own bone
- Considered the gold standard
- Commonly sourced from the iliac crest, but also obtained from the fibula, radius, ulna, hamstring tendons, and patella tendon
-
Allograft:
- Donated bone from living or deceased donors
- May include bones and tendons (lower limb)
-
Types:
- Cancellous bone: Great for osteoconduction but offers less structural support
- Cortical bone: Provides excellent structural support, but has a limited surface area and can be slow to incorporate into the recipient bone
-
Other attributes of allografts:
- Immunogenicity
- Disease transmission risk
- Structural integrity
- Depend on how the tissue is processed
Bone Substitute Options
-
Demineralized Bone Matrix (DBM):
- Allograft with the mineral phase (calcium compounds) removed
- Tissue is exposed to strong acids
- Variable osteoinductivity
-
OP-1 Implant (Collagen & BMP-7):
- A putty-like growth factor (BMP-7)
- Primarily osteoinductive
- Potential for adverse effects: infection, immune response, and lack of bone homeostasis
- Often used in combination with other bone healing products
-
Others:
- Xenograft: Bone from other species (e.g., bovine, porcine) used in dental implants, heart valves, and skin grafts
- Coralline hydroxyapatite: Ceramic-based bone substitute
- Ceramics: Various ceramic materials for bone regeneration
PlusLife
- A non-profit organization that retrieves, processes, and distributes donated human bone and tissue for transplantation purposes
- Also involved in research
- Statistics:
- 15,000 living donors
- 350 cadaveric donors
- 11,000 recipients
- 18,000 implants
Quality and Regulations
-
TGA Licenced Facility:
- Adheres to Good Manufacturing Practice (GMP) for Human Blood and Tissues
-
Quality assurance:
- Ensures product safety, effectiveness, and high quality
- Implementing controls for processes that can be controlled
- Assessing risks for processes that cannot be easily controlled
Process Controls
-
Bone donations:
- Donor screening and medical evaluation
- Strict criteria for donor eligibility
-
Histopathology:
- Microscopic examination of all bone tissue
-
Microbial tests:
- Tissue samples and swaps are tested for microbial contamination
-
X-rays:
- Performed on deceased donors to assess bone health
-
Terminal irradiation:
- Bone and tendons are sterilized using gamma irradiation (15kGy for soft tissue, 25kGy for bone)
-
Clean room (Grade-C):
- HEPA filtered air
- Low particulate walls
- Sterile instruments and consumables
-
Pressure gradients:
- To prevent contamination
-
Rigorous cleaning:
- Maintain a clean and sterile environment
-
Microbiology monitoring:
- Regularly assess for microbial contamination
-
Particle counting:
- Monitoring air quality to minimize particulate matter
Musculoskeletal Graft Applications
-
Orthopaedics:
- Joint replacement
- Infection
- Fracture repair (especially periprosthetic fractures)
- Fusion procedures
- Tendon and ligament repair
- Osteosarcoma
-
Maxillo-facial / Dentistry:
- Dental implants
- Craniofacial reconstruction
-
Other Applications:
- Urology
- Plastic surgery
- Neurosurgery
- Spinal fusion
- Trauma
Situations Where Bone Loss Occurs
-
Trauma:
- Fractures, especially open fractures
-
Surgery:
- Joint replacement surgery
- Bone tumor resection
-
Infection:
- Osteomyelitis (bone infection)
PlusLife Donor Programs
-
Living Donor Program:
- Patients undergoing total hip replacement (THR)
- Femoral head is typically discarded and replaced with an implant
- Can be donated
- ~800 femoral heads donated per year, resulting in 1200 allografts
-
Cadaveric Program:
- Donation of long bones and tendons from deceased donors
- Referrals through DonateLife
- ~12 cadaveric donors per year, contributing to 500 allografts
Exclusion Criteria (Donor Screening)
-
Ultra-conservative approach:
- Rigorous assessment of all donors
-
TGA Guidance:
- Strict guidelines for donor screening
-
Medical and Social History:
- Comprehensive review of medical and social history
-
Face-to-face donor interview:
- Especially for femoral head donations (FHD)
-
Key exclusion criteria:
- Past or present malignancy
- Autoimmune disorders
- Travel history
- Hepatitis B & C, HIV, HTLV, Syphilis
- Medications, previous surgery
Tissue Processing
-
Production planning:
- Careful planning to customize production sessions
-
Tissue clearance:
- Microbial results
- Histology results
- Physical examination
- Medical history (e.g., ACL repair)
- Commercial need
- Time available
-
Production setup:
- Conducted in a Class C cleanroom environment
- HEPA filtered air, non-shedding walls
- Sterile instruments and consumables
- Line clearance (remove potential contaminants)
- Gowned personnel
- Circulator and scrub person
- Double gloving
- Environmental and personnel monitoring
- Microbial testing
Cadaveric Processing
-
Debridement:
- Removal of soft tissues and contaminants from bone
-
Graft types:
- Various types processed from cadaveric bone and tendons, depending on intended use
-
Packaging:
- Careful packaging to maintain sterility and integrity of the graft
-
X-rays and photos:
- Documentation of the processed graft
Femoral Head Processing
-
Nibbling and cutting:
- Bone is shaped and sized for specific applications
-
Milling, washing, and packing:
- Further preparation and packaging for distribution
Bioburden Reduction - Irradiation
-
Terminal irradiation (gamma):
- Irradiated to kill any remaining microorganisms
- 15kGy for soft tissue, 25kGy for bone
-
Dispatched and stored:
- Graft is stored at a controlled temperature
Allografts
- A graft - organ, tissue, or cells - donated from one individual of the same species to another.
- Common allograft types include organs, musculoskeletal tissue, other tissue, and cells.
- Allografts have a significant therapeutic benefit and can be life saving or enhancing.
- Allograft transmission refers to the spread of infection from the donor to the recipient.
- "Allograft-transmissible" infections can be difficult to differentiate from regular infections due to the recipient's vulnerability post-transplant.
Transmission of Infections
- Transmission can occur via acute or latent/chronic donor infection.
- A single donor can infect multiple recipients.
- Lookback investigations involve testing donor-recipient pairs to identify potential infections.
- Transmission can also occur via contamination of the graft, including from the donor's normal microflora, environmental sources, or during processing.
Transmission Criteria
- The presence of HIV, HBV, or HCV in a donor does not necessarily contraindicate donation.
- Decisions about proceeding with donation and transplantation depend on recipient informed consent, the nature of the infection, other recipient clinical factors, and the availability of effective treatment.
- Reported examples of allograft-transmissible infections include Ehrlichiosis, Chagas disease, Hepatitis B, Hepatitis C, Hepatitis A, Tuberculosis, Legionnaires Disease, Listeriosis.
Prevention of Transmission
- Biological product safety tiers address both transmission and overall donor/recipient safety.
- Donor selection guidelines aim to minimize risks to both the donor and recipient and ensure graft functionality.
- These guidelines encompass a range of factors including medical conditions, medications, risk behaviors, travel history, and graft condition.
- Comprehensive screening involves a donor questionnaire and various tests to identify potential risks.
- The "window period" is the time between infection and detectable presence of an infectious agent in the bloodstream, which varies by agent and type of test.
Biovigilance
- A coordinated system to detect adverse events associated with biological products, encompassing traceability, quality control, and recalls.
- Passive recipient surveillance involves reporting events as they occur.
- Biovigilance tracks and monitors infection rates, trends, epidemiology, and non-compliance to identify and address potential issues.
Residual Risk
- Transmissibility criteria and agents constantly evolve due to factors like travel, climate change, globalization, emerging infectious diseases, vaccine hesitancy, and antimicrobial resistance.
- Risk reduction measures can include donor education, additional eligibility criteria, deferral from certain donation types, and new screening tests.
Risk Management
- Managing risk involves balancing the sufficiency of graft supply, cost and availability of intervention, and effectiveness.
- Risk tolerance and response vary significantly across different sectors due to factors like graft availability, time sensitivity, matching difficulty, graft urgency, and consequences of not receiving the graft.
Risk Comparison
- Blood donations have a relatively plentiful supply, donors are interchangeable, and transfusions are often indicated for minor reasons.
- Bone marrow donations require precise matching, donor pools are limited, graft performance varies, and decisions are highly individualized.
- Organ donations are scarce, timing is unpredictable for deceased donors, recipients may experience health decline or death while waiting, and transmitted infections can be serious, leading to individualized decisions.
Therapeutic Goods
- Therapeutic Goods Act 1989 defines ‘therapeutic good’ and ‘therapeutic use’
- The principal use and presentation of a product are key to determining if it is a food or a medicine
- Cosmetics are therapeutic goods if they contain sunscreen agents and claim to protect skin from UV radiation
- Excluded goods: hair bleaches, hair dyes, dental bleaches, dental whiteners, chemicals to harden finger nails, equipment to measure alcohol in body fluids, reproductive tissue for use in assisted reproductive therapy.
Regulation's Importance
- Thalidomide: Used in 1950s for morning sickness, later discovered to cause severe birth defects.
- Vioxx: A pain medication from the 1990s, later withdrawn due to serious health risks and led to $4.85 billion in legal claims.
- ASR Hip implant: Recalled in 2009 due to high failure rates.
- Poly Implant Prothese (PIP) Breast Implants: Removed from the market in 2010 for non-compliant manufacturing practices and health risks.
Regulatory Framework
- Therapeutic Goods Administration (TGA): Responsible for the quality, safety, and efficacy of therapeutic goods.
- The TGA administers the Therapeutic Goods Act 1989 and related regulations.
- The TGA works with consumers, healthcare professionals, industry, and international counterparts.
Biotherapeutic Goods
- Some biotherapeutic products are excluded from regulation as therapeutic goods, e.g., fresh human organs, haematopoietic progenitor cells, and autologous tissues and cells manufactured by a medical practitioner for single-indication treatment.
- Understanding the classification of a biotherapeutic product (medicine, medical device, or biological) is crucial for navigating the regulatory landscape.
Pre-market Regulation
- Biotherapeutic product evaluation involves reviewing safety, quality, and efficacy data.
- Safety and quality data: Includes information on donor selection, blood sampling, donor evaluation, and starting material collection.
- Manufacturing data: Covers manufacturer details, process description, transportation, labelling, storage, and validation.
- Non-clinical safety data: Includes biological dynamics, proof of concept, physiological effects, pharmacology, toxicology, and immunogenicity.
- Clinical data: Includes biodynamics, mechanism of action, biokinetics, dose-finding, clinical efficacy, adverse effects, and biovigilance/pharmacovigilance.
Cell Therapies and Regenerative Medicine
- FDA RMAT Designation (Regenerative Medicine Advanced Therapy Designation): Provides an expedited pathway for cellular and gene therapies intended for serious or life-threatening diseases.
- RMAT Eligibility Criteria: The therapy must be a regenerative medicine therapy, intended for a serious or life-threatening disease, and have preliminary clinical evidence demonstrating potential to address unmet medical needs.
RMAT Designation
- Benefits: Expedited approval pathway, increased meeting opportunities, priority review for marketing approval, and facilitated early patient access.
- Examples: MiMedx’s product AmnioFix Injectable for knee osteoarthritis, Ortho-ATI™ for resistant tendinopathy.
- FDA Statistics: As of 9th March 2018, 15 RMAT designations were granted.
Pathway to Regulatory Approval
- Innovation requires: Scientific excellence, clinical evidence of efficacy, risk evaluation, and cost-effectiveness.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
Explore the fundamental concepts of regenerative medicine, focusing on the roles of genes, cells, and the extracellular matrix (ECM). This quiz also delves into the historical milestones that have shaped the field, highlighting key figures and their contributions. Test your knowledge on how these components interact to promote tissue engineering and repair.